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Abstract 
Cervical Vertebral Maturation as a Valid Predictor of Growth 
S. HOSNI* J. E. HARRISON and G. BURNSIDE (School of Dentistry, The University of 
Liverpool, UK) 
Objectives: The primary objective was to assess if a correlation exists between CVM and 
statural height growth velocity. The secondary objective was to assess if a correlation exists 
between CVM and mandibular growth velocity. 
Design/Setting: A prospective longitudinal study undertaken at Liverpool University. 
Subjects: Participants were aged between 8-18 years, of either gender and enrolled from 
the orthodontic waiting list at Liverpool University Dental Hospital.  
Methods: Standing height was measured every 6 weeks with subjects barefoot and in 
natural head position. Lateral cephalograms were taken at the start of treatment, on 
completing functional appliance therapy and prior to debond. Lateral Cephalograms were 
traced and analysed digitally. A random 10% sample was retraced to assess the method 
error and reproducibiltiy. Mandibular growth was assessed using the area of the triangle 
condylion-gnathion-gonion to ensure data were comparable with previous research. Intra- 
and inter-observer reliability of CVM staging, cephalometric and statural height 
measurements were assessed using Cohen’s weighted kappa, intra-class correlation 
coefficient (ICC), and Bland and Altman plots respectively. ANOVA was used to test for 
statistically significant differences between statural height velocity and mandibular growth at 
CVM stages. 
Informed consent was obtained from parents/patients as soon as was reasonably possible 
after ethical approval was obtained. All participants underwent radiographic exposure in line 
with normal clinical practice; no additional exposure was required for this study. 
Reliability and Calibration: SH was calibrated in the assessment of CVM stage, to JH who 
had been calibrated in a previous study (Rainey, 2015). The intra-observer reliability of CVM 
index was perfect agreement (Kw 1). Inter-examiner reliability of CVM index was also perfect 
agreement (Kw 0.83, 0.96). Intra- and Inter-observer reliability for statural height 
measurements were excellent (ICC: 0.986-0.997). Intra-observer reliability of cephalometric 
measurements was good (ICC: 0.85-0.93). 
Results: 108 participants were included for analysis. The peak in statural height growth 
velocity occurred at CVM stage 3 (p=0.001). The peak in mandibular growth occurred at 
CVM stage 3, although this was not statistically significant. 
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CVM Stage Number of patients 
Mean annualized 
growth rate (cmy-1) 
Standard deviation 
(cmy-1) 
1 & 2 14 4.51 2.71 
3 22 9.39 4.44 
4 33 5.00 2.33 
5 & 6 39 1.56 2.34 
Total 108 4.59 4.06 
 
Table 1: Mean Annualised Growth Rate by CVM Stage (cm/yr) 
 
CVM 
Stage 
Area of Triangle 
Co-Go-Gn 
(cm2y1) 
Condylion-
Gnathion (cmy-1) 
Gnathion-Gonion 
(cmy-1) 
Gonion-
Condylion(cmy-1) 
1 & 2 
(N= 5) 
0.19 
 
0.38 
 
0.13 
 
 
0.19 
 
3 
(N= 11) 0.45 0.54 0.17 0.45 
4 
(N= 8) 
0.45 
 
0.54 
 
0.16 
 
0.45 
 
5 & 6 
(N= 12) 
0.26 
 
0.26 
 
0.08 
 
0.26 
 
 
Table 2: Mean change in annualized area of triangle Co-Go-Gn and linear 
measurements Co-Gn, Gn-Go, Go-Co. 
Conclusions: The findings of this study demonstrate that CVM staging is valid for identifying 
the pubertal peak in statural height. The peak in mandibular growth as assessed by the 
triangle Co-Go-Gn occurred at CVM Stage 3, but this was not statistically significant.  
 
Ethical approval was granted from Liverpool East Research Ethics Committee on 30th 
October 2013 with reference number 13/NW/0408 and protocol number UoL000751.  
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Chapter 1: Introduction 
 
Knowledge of craniofacial growth and development is fundamental to the comprehensive 
and successful management of orthodontic patients.1  It plays a vital role in the diagnosis, 
treatment planning, result and overall stability of the patients’ outcome.1   
Certain aspects of orthodontic treatment are achieved most effectively and efficiently when 
facial growth is occurring at a rapid rate, such as growth modification using functional 
appliances, reducing an overbite, and distalising buccal segments.2-5 During puberty, the 
rate of growth is faster than at any other time after infancy and is when orthodontic treatment 
is usually undertaken.6 It would therefore be helpful if the phases of treatment that relied on 
growth could be carried out during this period. 
Numerous methods have been investigated to identify the stage of growth and development 
and predict both the timing and potential of this growth.7-18 These include chronological age, 
dental age,7-9 menarche and voice changes,10, 11 standing height,12, 13 skeletal maturation of 
the hand and wrist,7, 8, 11, 14 and cervical vertebral maturation (CVM).15-18 
However, none of these methods have demonstrated a strong enough correlation to growth 
with the exception of skeletal age of hand wrist radiographs and cervical vertebral 
maturation.5, 7, 19-24 The principle of using skeletal maturity in order to determine the most 
appropriate time to carry out orthodontic treatment has varied in popularity, but has always 
required additional radiation exposure and additional skills for the orthodontist to interpret the 
hand wrist radiographs.25 As a result, alternatives to hand wrist radiographs were sought 
using investigations which were more common place in orthodontics and more familiar to the 
orthodontist to facilitate interpretation.26 CVM is an alternative method to hand wrist 
radiographs that has been shown to be reliable19, 20, 27-29 and does not require the use of 
additional radiation.20 This study aims to investigate the validity of CVM as a predictor of 
standing height and mandibular length. 
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Chapter 2: Literature Review 
2.1: Introduction 
An early approach to predicting facial growth and its extent was to compare the inherited 
characteristics between siblings and parents.30 Numerous authors, but all with very little 
success, investigated this approach.30-32 A review of the literature showed that neither 
chronological age nor dental development stages display enough correlation with individual 
maturational development to provide an adequate basis for treatment timing.33, 34 Many 
studies showed that there is great variation in the onset and extent of somatic growth at the 
initial stages of adolescence.12, 13, 35-37 Thus, it is argued that physiological measures of 
maturity, rather than chronological measures, should be preferred for assessing individual 
growth and development,13 so research then focused on biological indicators such as 
statural height, skeletal maturation of the hand and wrist and cervical vertebral maturation. 
Maturational variations have been shown to be closely associated with variations in the 
onset and amount of growth.5, 38 
The importance of knowing and being able to predict when the peak in growth will occur and 
has passed can readily be appreciated when different orthodontic treatment modalities are 
considered. Regarding class 2 skeletal relationships, the main aim of functional appliances is 
to induce growth modification and lengthening of the mandible by stimulating growth at the 
condylar cartilage.4, 39 How successful the functional appliances are will depend on the 
amount of growth at the condylar cartilage, which in turn depends on the growth velocity of 
patient.4 In contrast, treatment aimed at enhancing or restraining maxillary growth is more 
efficient when tackled before the adolescent growth spurt.15, 40 However, it is recommended 
that the best time for correction of mandibular prognathism is after the completion of 
mandibular growth.25 Thus, the importance of information regarding growth timing and 
potential is invaluable in order to obtain optimal orthodontic treatment results. 
2.2: Background and Rationale 
Knowledge regarding the timing and extent of growth for orthodontic patients is essential in 
order to manage them optimally and successfully, particularly in patients with skeletal 
discrepancies.1 Previously, numerous methods have been used in order to attempt to 
assess the growth and development stage of orthodontic patients.5, 7-17 However, limitations 
associated with previous methods of assessing growth have led to continued efforts to find a 
reliable and valid diagnostic tool that will accurately asses the stage of growth and 
development, in a manner that is easy to apply by the orthodontic profession. 
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The CVM staging index15 assesses the shape of the cervical vertebrae visible on a standard 
lateral cephalogram and uses this to predict the stage of growth and development of the 
patient. Whilst many studies have looked into the validity of this index,15-17, 19, 24, 41-48 most 
have used historical samples, and have been retrospective. Methodological flaws, as well as 
sampling issues, means that the validity of the CVM method is yet to be shown in a 
contemporary population sample in a prospective manner. 
2.3: Prediction of Growth and Development  
2.3.1: Chronological Age  
Often, the initiation of active orthodontic treatment is determined by the age of the patient as 
well as the stage of dental development.49 Chronological age has been shown to be an 
unreliable factor for establishing the stage of skeletal development;5, 7, 50 in addition, many 
authors have concluded that chronological age does not necessarily correlate with 
maturational age.5, 50 Furthermore, many studies have demonstrated significant differences 
in the timing of skeletal growth and development between males and females during 
adolescence.13, 50, 51 
Baccetti et al. concluded that chronological age showed a very low diagnostic value for the 
detection of the onset of the adolescent peak in skeletal maturation in both males and 
females.15 
Due to the large inter-individual variation that chronological age shows when correlated with 
developmental events around puberty, it is recommended that a biological indicator is used 
when evaluating individual skeletal maturity.13 Franchi et al52 assessed the stage of dental 
development and its relationship to the pubertal growth spurt. This study also provided data 
demonstrating the variability of chronological age with respect to onset of the pubertal peak 
in skeletal maturation, with the age range ranging from 8 years to 14 years and 6 months.52 
This wide variability emphasizes that there is little value in using chronological age as a tool 
for evaluating skeletal growth and maturation, especially with regards to orthodontic 
treatment planning. However, Beit et al. have recently suggested that chronological age may 
be as good as using other methods of assessing skeletal maturity.49 
2.3.2: Dental Development  
For many years, there has been debate regarding the relationship between the stage of 
development of the dentition and skeletal maturity. The literature reported inconclusive 
results with some reporting a high correlation between dental and skeletal ages22, 53 and 
some low and insignificant correlations.21, 54-56  
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Sierra suggested that although previous studies had shown low correlation between skeletal 
maturation and dental eruption or calcification, that this may have been due to using 
ossification centres that exhibited a wide variation in their onset.54 She therefore investigated 
the correlation using ossification centres that showed low variability in their onset, 
specifically the calcification of the mandibular canine, and concluded this showed a 
significant correlation between skeletal maturity and maturity of the dentition.54 
Most of the studies in the literature focus on the calcification or eruption of specific teeth, in 
particular, the mandibular permanent canines and the second permanent molars with a wide 
range of correlations reported between the point of calcification or eruption of teeth and 
skeletal maturation.7, 21, 50, 57, 58 No correlation has been shown between stage of dental 
development and mandibular growth52 and only weak correlations with the peak in statural 
height have been shown.7, 50 
Other studies, rather than focusing on the calcification or eruption of specific teeth, have 
looked at the phases of the dentition. The phases used were mostly the four classic 
developmental stages as defined by Bjork,59 the early mixed, the intermediate mixed, the 
late mixed and the early permanent phases. Franchi et al.52 found that the early mixed 
dentition was a useful indicator for the pre-pubertal stage of skeletal maturity as it scored 
highly as a diagnostic performance indicator for cervical stage 1 when correlated with CVM 
staging. The shedding of the deciduous incisors and eruption of the permanent incisors and 
first molars was concluded to be a powerful indicator of the pre-pubertal stage.52 It has been 
suggested previously that this stage may be the most appropriate and ideal time to start 
treatment aimed at altering maxillary growth with rapid maxillary expansion and the use of a 
facemask.42 However, in the same study, it was concluded that all the other phases of the 
dentition were not reliable indicators in determining the onset of the pubertal growth spurt 
which the authors take to be cervical vertebrae stage 3.52 When compared to a physiological 
indicator of skeletal maturity (such as the CVM or hand wrist maturation methods), dental 
development stage performs poorly in the evaluation of the onset of the pubertal growth 
spurt. 
2.3.3: Sexual Development  
The onset of puberty varies according to gender, population, and environment and shows a 
great deal of individual variation.7 Bjork and Helm showed that there was a close association 
between the age at the maximum increase in statural height and for girls, the age at the 
menarche.7   
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Hagg and Taranger however, showed that the peak in growth velocity preceded menarche.10 
It was later suggested that the menarche follows the peak growth spurt by an average of 
1.28 years.51 Although menarche can therefore give an indication of the post-pubertal peak, 
its presence indicates that the orthodontist has missed the pubertal growth peak, which for 
certain treatment modalities, is of little use. Hagg and Taranger also showed that with boys, 
once voice changes were complete, this indicated that growth was decelerating.10 Whilst 
useful to know that no significant further growth is likely to occur, it has limited use in 
predicting the event of peak growth velocity. 
In contrast, it has been shown that development of the testes in boys precedes the peak 
growth spurt and that this is a reliable indicator for predicting a forthcoming growth spurt.60, 61 
Despite the features that do show a strong correlation with the peak growth spurt, a valid 
question is how appropriate is it to attempt to ascertain this information from the orthodontic 
patient? Often patients feel sensitive about disclosing personal medical and social 
information that is routinely obtained, thus a line of questioning regarding pubertal 
development, such as the menarche and the development of the testes, is certain to cause 
embarrassment and may meet barriers to ascertaining the information required. As such, 
these features of sexual development may be deemed inappropriate, for an orthodontist, to 
ascertain and use to predict growth. 
2.3.4: Statural Height  
Expected height, weight, Body Mass Index (BMI) and height velocity for boys and girls are 
displayed in growth charts.  Various growth charts have been developed for assessment of 
children in the UK, which follow the development of children from birth to adulthood. They 
can be used, either for assessment and monitoring of an individual, or for screening a 
population.   They are based on longitudinal or cross-sectional population data. Both types of 
data have their methodological issues.  Longitudinal data suffers from the influence of time-
lag bias and is only generalisable to the population from which the data were derived.   
Cross-sectional charts are not strictly valid for monitoring growth over time.   The Royal 
College of Paediatrics and Child Health convened in 2002,62 with an expert group to provide 
guidance on the validity of available growth charts, including Tanner-Whitehouse,63 
Gairdner-Pearson,64 Buckler-Tanner65 and the UK 1990 growth references.66 They 
concluded that the ‘UK 1990’ reference is the only suitable reference that can be 
recommended’. 62  
More recently, the World Health Organisation has conducted a multicentre growth study to 
develop growth standards.67, 68 The WHO growth standards followed how children grew in 
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ideal conditions, from birth to two years.  They were based on children who were breast fed, 
in different countries around the world. This study compared the UK1990 and WHO data 
from 0-24 months; the WHO standard shows a slower rate of weight gain from 4-24 months 
for infants who were breast-fed only compared with mixed formula fed infants. This slower 
weight gain has been shown to be indicative of a reduced risk of obesity later in life.  From 
an ethnic point of view, the WHO growth standard may be more applicable to the current 
multinational UK population compared to the UK 1990 population, however, most infants in 
the UK, regardless of ethnic origin, are mixed or formula fed. This has lead to the 
amalgamation of the UK 1990 from 24 months to adulthood, and the WHO standards, from 
0-24 months,69 to form the current recommended growth charts for use in the UK.  
2.3.5: Somatic Development 
The timing of the growth spurt varies in different parts of the body, but for most facial 
dimensions, peak growth velocities occur at approximately the same time as in peak height 
velocity.33, 34 The peak statural height spurt occurs, on average at 12 years for girls and 14 
years for boys with a standard deviation of 1 year in both genders.5  
Disagreement exists in the literature regarding the evidence of a correlation between 
standing height and dentofacial growth.11,22,54,55 One body of researchers suggest that 
dentofacial growth is strongly correlated with standing height,11, 22, 55 whilst the other body 
reports a weak or insignificant correlation.54 It has been reported that the peak dentofacial 
growth velocity is reached after the peak statural body height.70 In contrast, Hunter in 
addition to other authors found that dentofacial growth velocity and statural height velocity 
coincided.13, 71 Nevertheless, flaws in the methodology, as well as different definitions being 
used and selection bias, means that there is little strong evidence to support or refute the 
argument either way. 
Summarising the discussion, Van der Beek,72 argues that comparisons are possible and 
measurable, as long as specific aspects of a growth curve, such as the onset and duration, 
are compared and correlated statistically to produce valid comparisons and conclusions. 
Mitani and Sato73 looked at the relationship between mandibular growth and numerous 
variables, including standing height, cervical vertebrae and hand-wrist bone maturation, in 
an attempt to look at a potential relationship between mandibular growth to other clinical 
variables during puberty. The conclusion of their study was that there was large variability in 
the onset and extent of the growth spurt between all the variables. Mandibular growth 
interestingly displayed the most variability and the authors concluded that orthodontists 
should be aware of the ‘unpredictable and random’ variation in mandibular growth, both the 
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onset and the magnitude;73 this having an effect on retention and stability as well as active 
treatment.  
Plotting height measurements against age would produce a line that continues to increase 
then level off, as statural height no longer increases. It can be difficult to recognise when the 
peak in statural height is from a serially plotted curve therefore most studies look at peak 
height velocity. Plotting the height velocity means that a growth curve easily illustrates the 
peak spurt, demonstrated by the highest point on the curve as illustrated by the graph in 
Figure 2.1. From Figure 2.1, it can be seen that after birth, the rate of growth decelerates 
with the exception of two phases. One is at approximately 6 or 7 years old but this is a 
relatively inconsistent phase. After this, a slowly decelerating phase exists until the second 
pubertal growth spurt occurs during adolescence. During puberty, the rate of growth is at its 
highest since the postnatal period, and an accelerated phase of increased growth occurs, 
often referred to as the ‘circumpubertal growth spurt’; and is when orthodontic treatment is 
normally undertaken. In both males and females, the Peak Height Velocity (PHV) is seen 
approximately two years after the onset of the pubertal growth phase. Growth velocity then 
slows to adult levels. The onset, duration and extent of growth can vary significantly among 
individuals of the same chronological age.74 
 
Figure 2.1: Average height velocity growth curve throughout stages of life from 
infancy to adulthood (MHV: minimum height velocity, PHV: peak height velocity). 
Adapted from Siervogel et al. 6  
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Statural height growth velocity is recognized as a useful measure of an individual’s growth. 
However, serious limitations exist regarding the practical use of these data for the prediction 
of future growth by orthodontists, as the peak in growth velocity may only be recognised 
after it has occurred, i.e. on a downward curve of a growth chart. The irregularity of the 
plotted curve makes it difficult to identify when the peak or spurt in growth is until it has 
passed. However, for the information to be useful, orthodontists would really need to know 
this information prior to this. Although the data would provide useful information that would 
allow the orthodontist to know that a patient has completed growth, perhaps in a case where 
there is a class III skeletal relationship, or where orthognathic surgery or implants were being 
considered, it would be of limited value in those cases where active growth is required to 
achieve the optimum treatment aims. 
Sullivan described measuring statural height longitudinally as a method of predicting the 
pubertal growth spurt in preparation for starting orthodontic treatment.75 He suggested 
routinely measuring standing height. The height velocity could then be calculated and plotted 
on a graph against age to give a height velocity chart. The point in a patient’s development 
which anticipates the occurrence of the peak in height velocity is predicted based on criteria 
set out in templates, one for males and one for females, outlined by Sullivan in his paper.75 
However, obtaining this information would necessitate orthodontists seeing potential patients 
for a significant period prior to commencing treatment.  
Tanner developed an onlay chart as part of the Harpenden growth study, which was placed 
over the height velocity chart and allowed the operator to determine which growth chart the 
patient was following and from which predictions could be made.60 However the limitations of 
this method include the Harpenden sample being historic and thus the data may not be 
applicable to the current population. Furthermore, the girls in the sample were in state care 
and many had emotional problems, which may have affected pubertal onset and restricted 
growth. The current growth charts have a supplemental guide for assessing pubertal stage 
using Tanner’s stage of puberty, however, these require a patient interview regarding the 
development of secondary sex characteristics, which may be inappropriate for patients 
seeking orthodontic treatment.   
Many authors have found a significant correlation between maturational stages from hand-
wrist radiographs and changes in standing height.38 Most of these studies compared skeletal 
maturation stages with one or many stages of growth such as the onset, peak, deceleration 
or maximum growth velocity. The majority of studies have placed the greatest significance 
on correlations found close to the time of maximum growth velocity.7, 38 
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In summary, many authors showed a high level of correlation of facial growth with general 
body growth (stature, standing height).33 In contrast, other authors argued that there was a 
low level of association.76 Of those who concluded that there was a strong correlation, some 
suggested that the facial growth peak was coincident with a standing height peak,13, 77 
whereas some suggested that the peak of facial growth usually occurs slightly later than the 
statural height peak.35, 78 Peak growth velocity is a useful longitudinal measure of an 
individual’s growth pattern but has limited use with regards to predicting the timing or extent 
of future growth. Longitudinal regular height assessment would be required to identify a 
higher velocity of growth, and despite this it may only be detected when the velocity curve 
begins to reduce thus, indicating that the peak in growth has been missed.79 
2.3.6: Skeletal Maturation  
The degree of maturation of certain bones can be used to assess skeletal and general 
maturation and development. Distinct bony changes in hand wrist radiographs as well as the 
knee and cervical vertebrae have been described in order to assess a patient’s skeletal age. 
2.3.6.1: Hand-wrist Radiographs  
Fishman developed an index using hand-wrist radiographs to evaluate skeletal maturity 
using a sample consisting of both longitudinal and cross-sectional groups.38 The underlying 
idea behind this theory was that osseous changes in the hand and wrist were indicators of 
more general skeletal changes. 
Looking at the previous work in the literature on which Fishman built, Greulich and Pyle first 
described an atlas method of predicting the skeletal age using hand wrist radiographs.14 The 
patient’s radiograph was compared with a standard series of radiographs, selected to be 
representative of normal children at different skeletal ages. The skeletal age was taken to be 
that of the standard film that the radiograph in question matched most closely. A criticism of 
this method was that as different bones all mature at slightly different rates, it may be difficult 
to decide on one standard film to which it matches most closely.5 
The Tanner and Whitehouse method used a weighted score designated to the stage of 
maturation of all 20 bones in the hand and wrist.80 The composite score for the radiograph 
then determined the bone age.80 
At this point, few studies had discussed single bone stages as criteria of skeletal maturity. 
Bjork discussed the use of specific bone stages to indicate whether the growth spurt had 
passed or not.34 However, Houston discussed the limitations of this method, arguing that the 
practical difficulties involved with serial observations will preclude its use in most clinical 
orthodontic situations.5 In addition, he argued that bone stages and ages have a huge 
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advantage in that a single radiograph can provide the information required.5 Although single 
bone stages can inform us whether the growth spurt has passed or not, they would not be 
useful in predicting the peak height velocity age. 
The methodology for Fishman’s study involved examining his sample in relation to specific 
maturational characteristics. Eleven discrete skeletal maturational indicators, (SMIs) 
covering the whole period of adolescent development, are found on six anatomical sites 
(shown in Figure 2.2) located on the thumb, middle and little fingers and radius using four 
stages of bone maturation38 (shown in Figures 2.3 and 2.4).  
 
Figure 2.2: Sites of Skeletal Maturity Indicators. Adapted from Fishman38 
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Figure 2.3: Radiographic Identification of Skeletal Maturity Indicators. A- Epiphysis 
equal in width to diaphysis B- Appearance of adductor sesamoid of the thumb C- 
Capping of epiphysis D- Fusion of epiphysis. Adapted from Fishman38 
The stages of maturation progress from widening of the epiphysis, ossification, capping of 
the epiphysis and fusion of the epiphysis and diaphysis and the SMIs are shown in Figure 
2.3. 
Width of epiphysis as wide as diaphysis Capping of epiphysis 
1. Third finger -proximal phalanx 
2. Third finger -middle phalanx 
3. Fifth Finger- middle phalanx 
4. Third finger -distal phalanx 
5. Third finger -middle phalanx 
6. Fifth Finger -middle phalanx 
 
Ossification Fusion of epiphysis and diaphysis 
7. Adductor sesamoid of thumb 8. Third finger -distal phalanx 
9. Third finger -middle phalanx 
10. Fifth Finger -middle phalanx 
 
 
Table 2.1: Individual Skeletal Maturity Indicators in chronological order. Adapted from 
Fishman38 
A B 
C D 
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Poor correlation between dental, maturational and chronological ages means that 
maturational indicators are a more valid means of judging physiological development than 
chronological age or dental development which can be misleading.81 Adolescents display a 
huge variation in growth, showing differing onsets of acceleration of growth, and it is here 
when the merit of hand wrist radiographs becomes apparent.  
However, the key limitations of the SMI index is that it requires an additional radiation dose 
for the orthodontic patient on top of the standard orthodontic diagnostic radiographs.25 
IRMER 2000 advises that the ionizing radiation dose must follow the principle of being as 
low as reasonably possible, and that clinicians should try to minimize the number of 
radiographs taken of patients, unless absolutely necessary.82 In addition to the extra 
radiation, the SMI index uses an anatomical area i.e. bones of the hand and wrist, that is not 
commonly studied in detail by orthodontists and thus it is not an area that they are skilled in 
interpreting. This may have implications for ease of use for the orthodontic or dental 
profession.4 
Further critique of Fishman’s work on skeletal maturation of hand wrist radiographs, was that 
although a longitudinal sample was used, allowing trends to be seen over time, it was a 
retrospective sample from the Denver Child Research Council.38 This study was active from 
1927 to 1967, so it started 55 years prior to the publication of Fishman’s work. Retrospective 
studies carry a high level of bias, and there would have been no standardisation as to the 
purpose of the study. In addition, the paper states that not all the hand-wrist radiographs 
were available for each period; this may have led to further bias in the study due to 
incomplete data. The cross-sectional sample was of the population at the time, but no 
information was given on how the sample was selected, whether it was randomly selected or 
if it was a sample of convenience.  
Despite these limitations, this study38 presented a technique of skeletal maturation 
assessment using hand wrist radiographs to facilitate the objective evaluation of 
maturational development and has been a very popular method. It is still commonly used 
today by orthodontists around the world, although not in the UK.83 It offers an organised and 
relatively simple technique to evaluate the maturation stage that is a more valid and reliable 
method than the use of chronological age or dental developmental stage.  
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2.3.6.2: Cervical Vertebral Maturation  
The routine use of hand-wrist radiographs has recently been questioned due to ethical 
issues regarding the additional radiation to which patients are being exposed.25 Recently, 
skeletal maturation assessment using cervical vertebrae maturation stages has gained in 
popularity due to its advantage of eliminating the need for additional radiation exposure, 
because the cervical vertebrae are already visible on the lateral cephalometric film that is 
frequently used to assist orthodontic diagnosis. Many studies in the literature have 
demonstrated the validity of the cervical vertebral maturation index to evaluate skeletal 
maturity instead of hand and wrist bones.19, 46-48 This method makes the evaluation of 
skeletal maturation easier and more applicable for orthodontists without the need to justify 
extra radiation to orthodontic patients.  
There are a number of advantages of using the CVM staging method over other previously 
discussed methods of assessing maturity and growth, and it is this index on which this 
research project will be based. The next section (2.4) will focus in detail on cervical vertebral 
maturation staging index, its inception, developments, strengths and shortcomings reported 
in the literature.14-17, 19, 39, 84-88   
2.4: Development of Cervical Vertebral Maturation Index  
2.4.1: Anatomy of Cervical Vertebrae  
The cervical spine consists of the first seven vertebrae in the spinal column. The first two, 
named the atlas and the axis, respectively are unique in shape.84 The third to the seventh 
vertebrae are similar in anatomy.84 As the vertebrae mature, changes can be seen in distinct 
stages from birth until full growth has been reached.89, 90 
After endochondral ossification of the vertebral body is complete, periosteal apposition on 
the front and sides of the vertebral body provides the means of growth.85, 86 Todd and other 
authors were the first to measure the cervical vertebrae from lateral cephalograms, although 
they looked at the lower vertebrae.87, 88 Lamparski is thought to be the first author to study 
the change in shape and size of the upper vertebrae (second to sixth) to create maturational 
standards for the prediction of growth.17  
2.4.2: Inception of Cervical Vertebral Maturation Theory  
In 1972, Lamparski completed his unpublished thesis titled “Skeletal Age Assessment 
Utilizing Cervical Vertebrae”.17 His aim was to determine whether the changes in maturation 
of the cervical vertebrae, seen on a standard orthodontic lateral cephalometric radiograph, 
could be used to evaluate the skeletal age of a patient. He used the method of Todd,91 which 
23/10/2015  
22 | P a g e  
 
had also been used by Greulich and Pyle,14 because at the time this method was the gold 
standard for determining skeletal ages. The cross-sectional sample was selected from the 
files of more than 500 Caucasian patients at the Orthodontic Department in the School of 
Dental Medicine, Pittsburgh, USA. Lateral cephalograms for a sample of 72 girls and 69 
boys were used to determine the standards. 
Maturity indicators were described and based on a selection of lateral cephalograms of a 
similar aged group of patients to those who were used as standards. The maturity indicators 
were observed changes that were demonstrated in all patients and signified a stage in 
development. To test the reliability and the validity of the standards, compared to the 
evaluations made from the wrist area, Pearson product moment correlation (r) and t tests for 
matched pairs were carried out. A sample of 25 boys and 25 girls who had lateral 
cephalograms and wrist films taken at the same time was used for this test.17 Lamparski 
concluded that there were no statistical differences between the maturation stage 
determined from the wrist and that determined from the cervical vertebrae and concluded 
that the cervical vertebrae could be used to predict skeletal age.17 He also found that the 
maturity markers were the same for males and females but that females matured earlier than 
males.17 
The indicators of maturity that the study concluded to be valid were the development of 
concavities in the lower border of the vertebrae as well as increased height of the vertebral 
bodies. The vertebral canal’s sagittal diameter and ossification of the vertebral ring were not 
found to be valid maturity indicators.17 Lamparski thus created maturational standards from 
C2 to C6, providing 6 stages of maturation based on the shape and lower borders of the 
cervical vertebrae. 
2.4.3: Developments to initial Cervical Vertebral Maturation Index  
Following on from Lamparski’s work,17 Hassel and Farman19 looked at lateral cephalogram 
radiographs and hand-wrist radiographs of patients from the Bolton-Brush Growth Centre. In 
a retrospective study using this historical sample, they correlated the stages of maturation 
and development and also agreed that CVM was a valid assessment of growth potential. 
The study described six distinct phases of vertebral maturation for C2, C3 and C4 involving 
changes in the shape (wedge shaped, square or rectangular), the vertical and horizontal 
dimensions and the curvature of the lower border. The six phases they described are shown 
in Figure 2.5. The sample was randomly selected from patients in the Bolton Brush growth 
study,92 and consisted of 220 patients, split equally into males and females. Inter-operator 
error and intra-operator error were accounted for in the results and were both insignificant.  
A significant limitation of this study however, was the retrospective and historic nature of the 
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sample, which affects how representative and applicable it would be to the current 
population. Another limitation discussed by the authors was that fact that maturation is a 
continuous process, yet the use of the CVM Index requires a distinct stage to be denoted to 
the CVM, thus it may be difficult to assign a stage to borderline cases. 
  
 
Figure 2.5: Cervical vertebral maturation indicators using C3 as a guide. Adapted from 
Hassel and Farman19 
Hassel and Farman,19 Bacetti et al.,16 as well as Pancherz and Szyska39 stated that the 
cervical vertebral analysis had a validity and reliability that was as comparabley high as the 
hand-wrist skeletal age assessment.  
Franchi, Baccetti and McNamara20 undertook a study to assess the validity of the method of 
cervical vertebral maturation for the evaluation of skeletal maturity and identification of the 
pubertal peak in craniofacial growth. They concluded that the method was valid, and 
reported the greatest incremental change in body height took place between stage 3 (when 
a concavity develops in the lower border of the third vertebrae) and stage 4 (when a 
concavity develops in the lower border of the fourth vertebrae and all the bodies of the 
cervical vertebrae become rectangular) as shown in Figure 2.6. In addition, they reported 
that the peak change in statural height, that occurred between stage 3 and stage 4, was 
accompanied by the peak change in mandibular dimensions and position.20 Although this 
study provided strong evidence to support the validity of the CVM method, the sample size 
was only 24 and was taken retrospectively from the University of Michigan Elementary and 
Secondary School Growth Study.  Along with the problems of bias due to its historic and 
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retrospective nature, it is not mentioned how the sample was selected and whether or not it 
was random. 
            
Figure 2.6: Six stages in cervical vertebral maturation (2000). Adapted from Franchi, 
Baccetti and McNamara (2000)20 
The main feature of the CVM method as described by Franchi, McNamara and Baccetti,20 
was the suggestion that the pubertal growth spurt (both statural height and mandibular 
growth) of almost 95% of North American patients coincided with the interval between Stage 
3 and Stage 4 of the CVM Index.20 They reported the predictability of this to be as high as 
98.6%. They stated that if either Stage 1 or 2 CVM was recorded for patients then they had 
not yet had their growth spurt. This is a useful marker for identifying and predicting 
mandibular growth in patients with a class 2 malocclusion for whom treatment with a 
functional appliance is being considered. 
Despite these advantages, there were some limitations to the CVM analysis. To make it 
easier to use and more applicable to the majority of patients, Franchi et al,20 thought that 
these limitations must be addressed. Firstly, when a protective radiation collar was worn 
(more common at the time their work was first published), only the second, third and fourth 
cervical vertebrae were visible on the lateral cephalogram.16 Thus it was suggested that the 
CVM method should only use cervical vertebrae C2, C3, C4, as previously suggested by 
Hassel and Farman.19 Secondly, previous CVM staging had also included comparative 
assessments to help decide at which stage the CVM was but this required a series of 
radiographs. It was therefore suggested that the description of each stage should be worded 
so that the assessment could be made from a single cephalogram.16 
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Consequently, the same authors later introduced an improved version of the CVM staging 
method that only used the second, third and fourth vertebrae and included five maturational 
stages, instead of the six, in the former method.16 The five-stage CVM index is shown in 
Figure 2.7 and its descriptions in Table 2.1. The advantage of the new method was that the 
skeletal maturity could be appraised on a single cephalogram. In addition, because only the 
assessment of the second, third and fourth vertebrae were required, it means that lateral 
cephalograms taken for patients wearing a protective collar, could still be used. Again the 
sample used by Bacceti, Franchi and McNamara,16 was taken from the University of 
Michigan Elementary and Secondary School Growth Study, thus presented the same 
limitations as discussed previously. 
 
Figure 2.7: The newly improved CVM method (five developmental stages, CVMS I 
through CVM VI). Different combinations of morphological features in the bodies of 
C2, C3, and C4 are presented for the new method. Adapted from Baccetti, Franchi and 
McNamara.16 
The improved CVM method is displayed in Figure 2.7. The descriptions for the five CVM 
stages were defined as detailed in Table 2.1. 
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CVM Stage Definition 
CVMS I The lower borders of all the three vertebrae are flat, with the possible 
exception of a concavity at the lower border of C2 in almost half of the cases. 
The bodies of both C3 and C4 are trapezoid in shape (the superior border of 
the vertebral body is tapered from posterior to anterior).  
The peak in mandibular growth will occur not earlier than one year after this 
stage. 
CVMS II Concavities at the lower borders of both C2 and C3 are present.  
The bodies of C3 and C4 may be either trapezoid or rectangular horizontal in 
shape.  
The peak in mandibular growth will occur within one year after this stage. 
CVMS III Concavities at the lower borders of C2, C3, and C4 now are present.  
The bodies of both C3 and C4 are rectangular horizontal in shape.  
The peak in mandibular growth has occurred within one or two years before 
this stage. 
CVMS IV The concavities at the lower borders of C2, C3, and C4 still are present.  
At least one of the bodies of C3 and C4 is squared in shape. If not squared, 
the body of the other cervical vertebra still is rectangular horizontal.  
The peak in mandibular growth has occurred not later than one year before 
this stage. 
CVMS V The concavities at the lower borders of C2, C3, and C4 still are evident.  
At least one of the bodies of C3 and C4 is rectangular vertical in shape. If not 
rectangular vertical, the body of the other cervical vertebra is squared.  
The peak in mandibular growth has occurred not later than two years before 
this stage. 
 
Table 2.1: Definitions of new improved CVM stages. Adapted from Baccetti, Franchi 
and McNamara.16 
Further to this, the same authors again reworked the CVM Index in 2005, reverting back to a 
six stage index, which is shown in Figure 2.8.15 They stated this revised version was a more 
valid and a more practical staging method to apply. Stage 1 and 2 were classified as pre-
peak stages, with the mandibular growth peak occurring between stage 3 and stage 4. Stage 
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6 described a stage that indicated that the peak in growth had occurred at least two years 
earlier. 
 
 
Figure 2.8: Schematic representation of the stages of cervical vertebrae according to 
the newly modified method. Adapted from Baccetti 2006.15 
2.4.4: Relationship of CVM to mandibular growth  
O’Reilly and Yanniello18 initially assessed the relationship of the CVM stage to mandibular 
growth using an historic sample, for 13 subjects, taken from the Bolton-Broadbent growth 
study.18 They reported that there was a positive association between cervical vertebral 
maturation and mandibular growth changes during puberty. Franchi20 corroborated these 
findings in their 2000 study in which they demonstrated that peak mandibular growth 
occurred between Stages 3 and 4 of the modernised CVM index. However, the sample size 
in this study was only 24 so the results must be interpreted with caution. 
2.4.5: Relationship of CVM to Standing Height  
Franchi et al,20 also reported that the peak velocity of change in statural height occurred 
between CVM stages 3 and 4, thereby linking the CVM stage to changes in statural height.20 
They found that 100% of boys and 87% of girls had their peak in growth velocity at this 
interval; this can be seen clearly in Figure 2.9.20 The findings demonstrated in the graphs in 
Figure 2.9 show that peak increases in statural height and mandibular length both occurred 
between stage 3 and stage 4.20 
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A: Females n=15 
 
B: Males n=9 
Figure 2.9: Individual changes in statural height at intervals between stages in 
cervical vertebral maturation. A: a subgroup of 15 females B: a subgroup of 9 males. 
Adapted from Franchi, Baccetti and McNamara.20 
2.4.6: Relationship of standing height to dentofacial growth  
There is scarce but strong evidence showing an association between standing height and 
dentofacial growth. Mitani and Sato made a good attempt when they explored a possible 
relationship of mandibular growth compared to numerous clinical variables including 
23/10/2015  
29 | P a g e  
 
standing height.73 However, they concluded that there was a large range of variability 
between the different variables and that mandibular growth showed the most variation, thus 
this association remains inconclusive.73 
2.4.7: Reliability of Cervical Vertebral Maturation Staging 
Any diagnostic tool must be both valid and reliable, yielding reproducible results in a 
consistent manner, measuring what it reports to measure with minimal inter- and intra- 
operator variation.81, 93, 94 The reliability of the CVM Index has been reported by many 
authors, with a range of results from perfect agreement to extremely poor agreement.41, 79, 95, 
96
 However, many of the studies have significant limitations that make it difficult to draw any 
solid conclusions. These include the sample size of the observers and/or images, the use of 
traced vertebral images rather than assessment using the radiographic image together with 
the use of observers who had increased knowledge and training of the CVM method or who 
were involved in its development. A systematic review, published by Santiago et al, 
highlighted these issues and suggested a more accurate method of testing reliability to 
determine whether the CVM index was a clinically applicable tool.97 To meet many of these 
limitations, Rainey in an unpublished thesis27 carried out a reliability study involving a group 
of 20 orthodontic clinicians, with a range of experience, and no previous training or 
experience in the CVM staging method. She assessed the reliability of staging 72 
consecutive lateral cephalograms over 2 phases. She reported an overall 89% intra-
observer agreement and 88% inter-observer agreement; concluding that the CVM staging 
method was reproducible and reliable. 
2.4.8: Validity of cervical vertebral maturation index  
Many authors have also discussed the validity of the CVM staging method. Mitani and Sato 
demonstrated a correlation between changes in the cervical vertebrae and mandibular 
size.73 Several authors have found a significant correlation between CVM and skeletal 
maturation of the hand-wrist bones.16, 19, 39 Finally, Baccetti and Franchi demonstrated the 
validity of this method with regards to predicting the pubertal peak and evaluating skeletal 
maturity in their work, also using hand-wrist radiographs as a reference.15, 16, 20 However, 
Engel et al.98 have recently suggested that the CVM staging method could not predict 
craniofacial growth in girls with a class 2 malocclusion, but this study was based on a 
sample of girls from the Nijmegen growth study, which was published in 1979 and thus 
comprised of a historic sample, thus its relevance and generalisability to today’s children is 
questionable.  
It would seem therefore, that cervical vertebral staging is probably a valid method of 
assessing skeletal maturity. The appeal of this index to orthodontists, if proved to be valid on 
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an appropriate sample, is that it uses information that is readily available to us on a lateral 
cephalogram, which is taken routinely for orthodontic diagnosis and thus does not require 
any additional radiation exposure. However, to date, all the studies that have assessed the 
validity of CVM staging have used historic samples and have been conducted in a 
retrospective manner. The validity has not yet been prospectively investigated using a 
contemporaneous sample.  
2.4.9: Summary of Main Growth studies  
There are a number of longitudinal growth studies, most of which were undertaken in the 
United States roughly between 1930 and 1985.92 Collections of radiographic images (both 
lateral cephalograms and hand-wrist radiographs) and other records of craniofacial 
development of growing children with malocclusions who did not receive orthodontic 
treatment have been archived at various Universities in North America.  
Prior to 1930, the cephalostat was not in use and thus standardized imaging of the 
craniofacial region was not routinely being undertaken. Towards the late 1900s the harmful 
effects of ionizing radiation had been recognised and legislation was starting to come into 
effect about the exposure of patients to ionising radiation. Thus, longitudinal studies of this 
nature are unlikely to be repeated. The information from these longitudinal studies has been 
of significant value to the orthodontic profession with regards to studying the natural course 
of growth of the subjects in the growth studies. The main growth studies are summarised in 
the table below (Table 2.2).  
These growth studies have been used as a sample or control group for many of the CVM 
reliability and validity studies.92 However, it is recognised that populations change with time, 
and what may have applied to a historic sample, may no longer be valid.93 This is a common 
issue for studies that have used samples from historic growth studies. Although these 
studies have contributed to our knowledge of growth and development, the findings of 
studies that use samples from historic growth studies must be interpreted with caution due to 
their limitations.  
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Name of Study Institution Date Original 
Author and 
Curator 
Number 
of 
subjects 
Details Records 
The Case 
Western Bolton 
Brush Growth 
Study 
Bolton Brush 
Growth Study 
Centre, Case 
Western 
University 
1930-1977 B. Holly 
Broadbent 
Sr. (Bolton 
Family) 
(Curator 
Mark G 
Hans) 
4309 Houses largest human craniofacial 
growth study in world: Broadbent-
Bolton Growth study and largest 
longitudinal growth study: the Brush 
Inquiry 
Radiographs (lateral 
cephalograms, hand 
wrist radiographs) 
Study Models (SMs) 
The University 
of Toronto 
Burlington 
Growth Study 
 
Department of 
Orthodontics, 
Dental School,  
The Burlington 
Growth Centre 
University of 
Toronto 
1952- Dr. Robert 
Moyers 
Curator 
Bryan D 
Tompson 
1258 The predominant racial group was 
Caucasian & mostly Anglo Saxon. 
To date, there have been 339 
studies using the Burlington Growth 
Centre information. 
Cephalometric 
radiographs, hand-wrist 
radiographs, SMs Height 
and weight; photographs 
The University 
of Oklahoma 
Denver Growth 
Study 
 
Department of 
Orthodontics - 
Dental School, 
University of 
Oklahoma 
1927-1967 Curator G. 
Fräns 
Currier 
313 Untreated children, European 
Caucasians 
Lateral Cephalograms 
Handwrist radiographs 
Facial photographs 
Study Models 
Full body photographs 
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Name of Study Institution Date Original 
Author and 
Curator 
Number 
of 
subjects 
Details Records 
The Wright 
State 
University Fels 
Longitudinal 
Study 
 
Lifespan 
Health 
Research 
Center - Wright 
State 
University 
1929-1982 
(cranial 
radiographs 
terminated) 
Curator 
Richard 
Sherwood 
1200 Largest and longest running study 
of human growth over the lifespan 
(Roche, 1992). Study participants 
live in or near southwest Ohio 
(Indiana, Kentucky, West Virginia) 
and were born between 1929 and 
present.  
Lateral Cephalograms 
Handwrist radiographs 
Knee radiographs 
The Forsyth 
Institute Twin 
Sample 
 
Forsyth 
Institute 
 
 Dr. 
Coenraad 
Moorrees 
Curator 
Ahmet Keles 
533 
families 
with 
twins or 
triplets 
recruited 
The Forsyth twin sample is perhaps 
the largest prospective growth 
sample collected on twins and their 
families. The sample was collected 
as part of a federally funded project 
carried out at the Forsyth Infirmary 
for Children in Boston, 
Massachusetts 
Lateral (open and closed 
mouth) and 
posteroanterior 
cephalograms, incisor 
periapicals during incisor 
eruption, hand-wrist 
films, SMs. 
 
The Iowa Facial 
Growth Study 
 
Department of 
Orthodontics - 
College of 
Dentistry, 
University of 
Iowa 
1946-1968 Howard V. 
Meredith 
and L. B. 
Higley 
Curator 
Thomas E. 
Southard 
183 Although the study is called “Facial 
Growth,” numerous trunk and limb 
measurements also measured. 
Height, weight, dietary information, 
and medical history data included. 
SMs, anterior and profile 
photographs, and full 
intraoral radiographs, PA 
and lateral cephalometric 
radiographs  
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Name of Study Institution Date Original 
Author and 
Curator 
Number 
of 
subjects 
Details Records 
The UOP 
Mathews 
Growth Study 
 
Collected at 
University of 
California at 
San Francisco  
1967-1979 Dr. J. 
Rodney 
Mathews 
Curator 
Sheldon 
Baumrind  
36 The Mathews Implant Growth Study 
collection is uniquely important 
because it is the only longitudinal 
cephalometric record set from 
subjects with Björk type implants. 
Lateral, PA, and oblique 
cephalograms  
The Michigan 
Growth Study 
 
Department of 
Orthodontics 
and Pediatric 
Dentistry, Ann 
Arbor Campur, 
University of 
Michigan 
1935-1970 
 
 
Curator 
James A. 
McNamara  
721 
individua
ls 
150 
families 
Subjects primarily Northern 
European ancestry. Bias toward 
Class II malocclusion and 
increased lower anterior facial 
height, with only a very few 
individuals presenting with Class III 
malocclusion. 
Lateral cephalogram 
closed, lateral 
cephalogram open, 
posteroanterior, lateral 
obliques (2), and 
hand/wrist films. 
 
The Oregon 
Growth Study 
 
Department of 
Orthodontics - 
School of 
Dentistry, 
Oregon Health 
and Science 
University 
1950-1975 Curator  
David A. 
Covell Jr. 
357 The records were collected from 
untreated Caucasian individuals, 
either semiannually or annually 
Photographs, SMs, 
lateral (closed and 
open), P-A, hand-wrist 
and intraoral films, 
growth charts, diet 
records, and health-
histories. 
 
Table 2.2: A summary of the main growth studies; Adapted from American Association of Orthodontists Foundation: Craniofacial 
Growth Legacy Collection92
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2.5: Readability of Information 
Evidence suggests that patients overall satisfaction with a clinician is increased if they are 
given and understand, information and advice provided.100 It has been shown that patients 
forget or misunderstand much of what is discussed during a consultation.101 It has been 
reported that patients will retain 20% of what is discussed but this will increase up to 50% if 
there is additional visual or written input.102 George et. al.103 demonstrated that patients 
favoured written information and that patients who were given leaflets were more satisfied 
with their treatment as a whole.  
Although participating in the current study did not involve any treatment for the participants 
and merely involved participants having their height measured, it was anticipated that 
patients and parents would be happier if they were provided with adequate information about 
the study that was communicated at the appropriate level. Weinman104 confirmed the desire, 
use and value of leaflets by patients, showing that 75% of patients wanted written 
information and that 80% read the leaflets. 
Readability formulae assess the structural elements of text and are designed to measure the 
reading difficulty or the ease with which written text can be understood by a reader.105 The 
readability of a particular text depends on both its content (for example the complexity of its 
vocabulary) and on its typography (for example its font size, line height and line length). 
There are over 50 published readability formulae that produce a score or number that 
indicates to what extent a piece of text is readable.100 Most are based on the theory that 
longer words and sentences are harder to understand.105  
Reading abilities vary widely across a population and across different age groups so it is 
important that information is pitched at a suitable level for it to be understood by the target 
audience.106 It is a common finding that patient information leaflets (PILs) tend to be written 
at too high a level for the target audience. Harwood and Harrison105 looked at 26 orthodontic 
PILs from professional organisations and commercial companies and found that the mean 
readability of all the PILs was rated as ‘fairly difficult’, meaning that only 40% of the UK 
population would be expected to understand them. 
2.5.1: Flesch-Kincaid Reading Ease 
In the Flesch Reading Ease test, higher scores indicate material that is easier to read; lower 
numbers indicate that the text is more difficult to read.107  
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Rudolf Flesch published his Reading Ease formula in two parts in 1948.107 Rather than using 
grade levels, it used a scale from 0 to 100, with 0 equivalent to the 12th grade (USA) and 100 
equivalent to the 4th grade (USA). The second part of the formula predicts human interest by 
using personal references and the number of personal sentences. The original formula is: 
Reading Ease score = 206.835 – (1.015 x ASL) – (84.6 x ASW) 
Where: ASL  = average sentence length  
= Number of words   
   Number of sentences 
ASW = average word length in syllables  
= Number of syllables  
   Number of words 
 
The Flesch Reading Ease formula became one of the most widely used, and the one most 
tested and reliable. In 1951, Farr, Jenkins and Patterson simplified the formula further by 
changing the syllable count108. The modified formula is: 
Reading Ease score = 1.599NOSW – 1.015SL – 31.517 
Where: NOSW= number of one-syllable words per 100 words and  
SL= average sentence length in words 
2.5.2: Flesch–Kincaid Grade Level 
In 1975, in a project sponsored by the U.S. Navy, the Reading Ease formula was 
recalculated to give a grade-level score. This new formula uses the "Flesch–Kincaid Grade 
Level Formula" to translate the 0–100 score to a school grade level, facilitating the 
categorisation of readability level of texts.107 The result is a number that corresponds with a 
grade level. For example, a score of 8.2 would indicate that the text is expected to be 
understandable by an average student in year 8 (aged 12-13 years) in the United Kingdom. 
The Flesch-Kincaid formula is one of the most popular and heavily tested formulas.  
2.5.3: Gunning Fog Index 
This index estimates the years of formal education needed to understand the text on a first 
reading.109 Robert Gunning developed this index in the 1940s whilst he was running a 
readability consulting firm which was dedicated to reducing the ‘fog’ in newspapers. In 1952, 
he published the Gunning-Fog Index,109 a formula that is reliable and simple to apply: 
Grade level = 0.4 x [(average sentence length) + (percentage of Hard Words)] 
Where: Hard words = words with more than 2 syllables. 
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A Fog index of 12 requires the reading level an 18 year-old. Texts for a wide audience 
generally need a Fog index of less than 12. Texts requiring almost universal understanding 
need a Fog index of less than 8.  
2.5.4: SMOG 
The SMOG grade is another measure of readability.110 It was published by McLaughlin in 
1969, and he determined that word length and sentence length should be multiplied rather 
than added as in other formulae. The SMOG formula is: 
SMOG grading = 3 + square root of polysyllable count 
Where: polysyllable count = number of words more than two syllables in a sample of 30 
sentences. 
The SMOG grade is thought to be more accurate and more easily calculated than the 
Gunning-Fog index and recently it was concluded that the SMOG grade was the gold 
standard formula for consumer-orientated healthcare materials with regards to readability 
formulae.111 
2.5.5: Automated Readability Index 
The Automated Readability Index (ARI) is a readability test that produces an approximate 
representation of the US grade level needed to comprehend the text.112 The formula for 
calculating the ARI is: 
ARI = 4.71 (characters / words) + 0.5 (words / sentences) – 21.43 
Where: characters: is the number of letters, numbers and punctuation marks 
Words: is the number of spaces 
Sentences: is the number of sentences 
US grade level 1 corresponds approximately to ages 6 to 8. Reading level grade 8 
corresponds to the typical reading level of a 14 year-old child.  
In order for the information material to be readable to the majority of our participants and 
their parents, information about the study was written in a simple form and assessed using 
the above criteria prior to ethical approval being granted. 
2.6: Measuring Mandibular Growth 
There was much discussion on how the velocity of mandibular growth should be assessed. 
Mandibular growth occurs as the result of a heterogeneous pattern of bone resorption and 
apposition.113 Our current knowledge of the extent to which the mandible changes and 
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rotates during growth mostly derives from classical longitudinal studies that were based on 
serial two-dimensional cephalometric radiographs superimposed on bone markers.114 This 
approach, however, has questionable accuracy, is prone to measurement error, and the 
information obtained is limited by the two-dimensional nature of the image.115 The 
introduction of three-dimensional radiographic imaging with cone-beam computed 
tomography (CBCT) now allows quantitative and qualitative analysis of bone remodelling 
that could potentially allow the original concepts of growth to be reassessed. However, 
ethically for the purposes of this study, this type of radiographic imaging, for the purpose of 
determining the velocity of mandibular growth, was not appropriate. 
This led to a quandary as to how the velocity of mandibular growth should be determined. It 
was thought that looking to previous research to see what previous authors had done would 
allow the use of a method that was comparable to other research done on this topic. Franchi 
et al20 used two triangles as shown in Figure 2.10; Co-Gn-Go and S-Gn-Go. There are 
advantages associated with each of these triangles. Using sella as a reference point to 
gnathion and gonion provides a stable reference from which forward anterior-posterior and 
vertical growth can be assessed. However, using condylion would provide possibly a more 
accurate measure of mandibular growth, as it would take into account growth or remodelling 
that had occurred at the condyle. This would hopefully mean that growth in any direction 
would be taken into account when measuring the area of the triangle Co-Gn-Go.  
 
Figure 2.10: Measurements used to assess mandibular growth in the Franchi et al 
2002 paper. Modified from Franchi et al.20 
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Several other methods of assessing mandibular growth have been described in recent 
research. O’Brien et al116 used Pg/Olp and Co/OLp from the Pancherz analysis to assess 
skeletal changes that had occurred after the use of functional appliances. However, in his 
discussion of randomised clinical trials on treatment of class II malocclusions, Miekle reports 
that the analysis of Pancherz (1982), underestimates mandibular growth, as it is a linear 
measurement that does not take into account individual variation in condylar growth 
rotation.117  
Others methods of measuring mandibular growth that have been described in the literature 
include using Co-Pg118,119 and Co-Gn120 to describe mandibular changes. Mitani and Sato73 
looked only at condylion-gonion to assess mandibular growth, with the idea that this would 
take into account both vertical and antero-posterior mandibular growth that had occurred. 
This, however, may result in any growth or remodelling at the angle of the mandible being 
missed. 
Hunter,13 when assessing mandibular growth in relation to standing height and skeletal 
maturation, used 7 linear measurements; Ar1-Go6, Go6-Po5, Ar1-A4, S2-N3, S2-Go6, N3-M, 
shown in Figure 2.11. Bishara et al. also used articulare, but instead used articulare-
pogonion to assess mandibular length.121 Articulare has high reproducibility, however, it 
does not show full mandibular length. Articulare will not undergo the same positional change 
following a change in the amount or direction of growth in the mandible. In addition, 
measuring mandibular length with articulare introduces the possibility of a false interpretation 
of an increase in mandibular length, if the condyles are positioned anteriorly within the 
glenoid fossa,  
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Figure 2.11: Measurements used to assess mandibuar growth in Hunter (1966). 
Modified from Hunter.13 
As the research carried out by Franchi et al.20 was most similar to this study, with similar 
outcome variables, it was thought that it was most appropriate to have comparable data to 
their research. To avoid an excess of spurious data, it was decided that the triangle Co-Gn-
Go to assess mandibular growth should be used. 
One of the problems with using this assessment was the difficulty in defining the head of the 
condyle (condylion) on a lateral cephalogram. Condylion is well documented to have a high 
degree of error in its identification.122 Adenwalla suggested that if the mandibular condyle 
has to be used as a landmark in a study, that an open mouth cephalogram should be taken 
and superimposed on the respective cephalogram in normal occlusion, to obtain the most 
accurate and reliable measurements.123 However, there is conflicting evidence in the 
literature as to whether an open mouth cephalogram does indeed improve the accuracy and 
reliability of the identification of condylion.123, 124 In addition, for the purposes of this research, 
as cephalograms that had already been taken for orthodontic treatment planning in the 
closed mouth position,were being used, the open mouth method was not an option.  
Furthermore, Meikle has suggested that the linear dimension condylion-gnathion will be 
strongly influenced by condylar growth rotations.117 In using cephalometric radiographs to 
assess mandibular growth, it is almost impossible to identify and accurately measure 
mandibular growth rotations. It has been shown that longitudinal growth of the mandible is 
23/10/2015  
40 | P a g e  
 
confined to the condyle and the direction of condylar growth is highly variable,12, 125 thus 
highlighting the importance of considering growth rotations when assessing mandibular 
growth. The limitations of cephalometrics must be taken into account, and cephalometric 
data critically assessed.  
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Chapter 3: Rationale for Research 
 
The importance of determining a patient’s growth stage has been clearly described1, 20 and 
the CVM index provides a tool that is easy to apply, readily available to orthodontists and 
has been shown to be reliable.27 Previous research carried out on the CVM method has 
focussed on its inter- and intra-observer agreement27,126 and on determining the correlation 
between the CVM index and the hand-wrist radiograph index.16, 19, 39 
 
However, research validating CVM with regards to the prediction of growth, both standing 
height growth and mandibular growth is sparse.  Despite the index having been shown to be 
valid,16, 20, 52 the existing research has been retrospective and has used historic samples 
from growth studies carried out in the US started in the early 1900s.  
 
For the CVM method to be of use clinically today, it must not only be reliable but it must also 
be valid with respect to its predictability of growth in a contemporary sample. The aim of this 
study is therefore to determine the validity of the cervical vertebral maturation as a predictor 
for growth using an appropriately sized contemporaneous sample in a prospective manner. 
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Chapter 4: Lateral Cephalogram Audit 
 
There are many benefits of applying the Cervical Vertebral Maturation (CVM) staging 
method to assess the stage of growth and development at which orthodontic patients have 
reached. The use of this method can allow the orthodontist to make much more informed 
decisions regarding the timing of treatment and treatment modalities. The CVM staging 
method has been shown to be reliable.27 However, in order to use this method, the second, 
third and fourth cervical vertebrae need to be visible on the lateral cephalogram. 
 
4.1: Aim 
The aim of this audit was, therefore to evaluate whether lateral cephalograms, taken at 
Liverpool University Dental Hospital, routinely included the second, third and fourth cervical 
vertebrae, allowing application of the Cervical Vertebrae Maturation (CVM) staging index 
(Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: CVM Index taken from Baccetti et al.15 
4.2: Standards 
All lateral cephalograms should include the second, third and fourth cervical vertebrae3 and 
the cervical vertebrae image should be a sufficient diagnostic quality.   
The standard was therefore set that 90% of lateral cephalograms would have a clear 
representation of the second to fourth cervical bodies. 
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4.3: Design and Setting 
This was the third phase of an on-going audit looking at lateral cephalograms from three 
consecutive first year Specialty Registrar (StR) patient cohorts at Liverpool University Dental 
Hospital. The audit was registered with the clinical effectiveness unit. 
In the first audit, undertaken by B-J Rainey, all lateral cephalograms requested by first year 
orthodontic registrars from the 1st October 2010 to 31st January 2011, were assessed 
retrospectively for the inclusion of the second, third and fourth cervical vertebrae and the 
ability to stage the CVM (Figure 4.2). The target was not met and failure to attain the target 
appeared to be a result of the patient being positioned incorrectly in the cephalostat, with the 
patient’s neck often appearing hyperextended. 
As a result of this, staff in the radiology department were provided with appropriate training 
on positioning patients correctly in natural head posture when having a lateral cephalogram 
taken. After a washout period, the second cycle was carried out to assess if there had been 
an improvement. 
The second stage of the audit, also undertaken by B-J Rainey, looked at lateral 
cephalograms taken from October 2011 to January 2012.  
This third phase hoped to complete the audit cycle and looked at a randomly selected group 
of 80 lateral cephalograms taken between October 2012 and January 2014.  
 
 
A) CV2,3,4 displayed        B) CV2,3                   C) Only CV2 displayed 
             
Figure 4.2: Assessment Criteria: Lateral cephalogram clearly displaying: A) CV2, CV3 and 
CV4, B) CV2 and CV3, C) Only CV2  
4.4: Results 
First audit October 2010-January 2011 
In the first audit cycle undertaken by B-J Rainey, a total of 264 lateral cephalograms were 
assessed. Of these radiographs, 100% of them displayed CV2, 97% clearly displayed CV3, 
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however, only 83% of the lateral cephalograms clearly displayed CV4. Thus, only 83% of the 
radiographs were suitable for the application of the CVM method described by Baccetti.38 
(Table 4.1). 
In the first audit the target, of 90% of lateral cephalograms having CV2, 3 and 4 displayed, 
was therefore not achieved.  
 
Second Audit October 2011- January 2012 
In the second cycle (B-JR), 134 lateral cephalograms were assessed.  Again, all lateral 
cephalograms in this sample clearly displayed CV2.  The percentage clearly displaying CV3 
increased to 100% and the percentage clearly displaying CV4 increased to 93%.  Therefore, 
CVM staging could be applied in 93% of cephalograms assessed (Table 4.1).   
Overall, the ability to stage lateral cephalograms using the Baccetti15 method of CVM staging 
improved from 83%, in the initial audit, to 93% in the re-audit.  This improvement was 
statistically significant [OR 2.72 (1.08, 6.89)].   
 
Third Audit October 2012- January 2014 
In the third cycle, undertaken by SH, 80 cephalograms were assessed according to the 
same criteria. All the lateral cephalograms displayed CV2. The percentage displaying CV3 
was 96% and 85% displayed CV4. Therefore CVM staging was possible in 85% of 
cephalograms assessed. 
Overall, from the second phase to the latest (third phase) re-audit, the ability to stage lateral 
cephalograms using the Baccetti method of CVM fell from 93% in the first to 85% in the final 
audit cycle. Nevertheless, this change was not statistically significant [OR 0.41 (0.16-1.02)] 
but the target of 90% of cephalograms having CVM 2, 3,4 visible was again, not met.
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Table 4.1: Results from first audit (October 2010-January 2011), second audit (October 2011- January 2012) and third audit cycle 
October 2012-January 2014). 
 Number. of 
Cephs 
Number 
with C2 
% with C2 Number 
with C3 
% with C3 Number 
with C4 
% with C4 Number 
with 
CVM2,3,4 
% All with 
CVM2,3,4 
FIRST AUDIT  
OCT 2010-JAN 2011 (BJR) 
264 264 100% 256 97% 219 83% 219 83% 
SECOND AUDIT  
OCT 2011-JAN 2012 (BJR) 
134 134 100% 134 100% 125 93% 125 93% 
THIRD AUDIT  
OCT 2012-JAN 2014 (SH) 
80 80 100% 77 96% 68 85% 68 85% 
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4.5: Discussion 
The first audit found that 17% of the lateral cephalograms were not suitable for application of 
the CVM method.  This was similar to a clinical trial that reported that it was not possible to 
stage 16% of lateral cephalograms using the Hassel and Farman method as the radiographs 
were not clear in the cervical vertebrae region.127 
The results of the audits undertaken at Liverpool University Dental Hospital show that CV2 
was present on all cephalograms and it was CV3 and/or CV4 that were not visible.  It was 
identified that this was a result of patient positioning because when patients were positioned 
with their neck hyperextended, rather than in a more vertical position, and not in natural 
head position, the cervical bodies of CV4 and CV3 may be cropped from the radiographic 
field.  Poor patient positioning has been confirmed in the literature as a significant factor in 
the accuracy of determining the CVM Stage.128 Torres et al. showed that upward or 
downward head inclination adversely affected the ability to evaluate the CVM stage and that 
inter-observer agreement was higher in the lateral cephalograms taken in natural head 
position.128 
In the third audit cycle, although it appears that the number of radiographs to which the CVM 
method can be applied has fallen again, the sample size was significantly lower and so even 
though randomly chosen, may not have been representative. 
Another potential reason for this variation is the nature of Liverpool University Dental 
Hospital (LUDH) as a teaching hospital whereby a number of trainee radiographers pass 
through the department, meaning that the radiographers who received the training in 2011, 
may not have been those who were taking the radiographs in the most recent audit. This will 
be a general problem encountered in all teaching hospitals and thus it may be helpful to 
include this information about patient positioning in the cephalostat as an on-going 
educational programme, when training new radiographers to take lateral cephalograms. 
4.6: Conclusion 
The target, that 90% of lateral cephalograms had the second, third and fourth cervical 
vertebrae clearly visible, was met in the second cycle but was not met in the first and third 
cycles. Providing training to the radiographers who were taking the lateral cephalograms 
significantly increased the number of lateral cephalograms that displayed the second, third 
and fourth vertebrae, thus allowing the 90% standard to be achieved in the second audit. 
However, this was not maintained in the long term and measures need to be taken to ensure 
the ongoing training of radiographers in the radiology department at LUDH. 
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4.7: Recommendations  
Failing to display the second, third and fourth cervical vertebrae clearly on a lateral 
cephalogram is usually a result of incorrect patient positioning in the cephalostat. Discussions 
have been held with the consultant radiologist at LUDH in an attempt to determine the best 
way of ensuring that the radiographers position patients correctly in the cephalostat. 
Agreement was obtained to place a poster close to the cephalostats illustrating the ideal head 
position to ensure that CVM 2,3,4 are included on the lateral cephalogram, Following this, 
J.Mangan, orthodotic StR will re-audit the lateral cephalograms taken following the instigation 
of any training package and use of an ‘aide memoir’. 
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Chapter 5: Study Objectives 
5.1:  Primary Study Objective  
To assess if a correlation exists between CVM Stage and statural height growth velocity. 
5.2: Secondary Study Objectives 
To assess if a correlation exists between: 
1. CVM Stage and mandibular growth velocity. 
2. Mandibular and statural height growth velocities. 
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Chapter 6: Null Hypothesis 
6.1: Null hypotheses 
There is no correlation between CVM Stage and statural height growth velocity against the 
alternative hypothesis of a correlation. 
There is no correlation between CVM Stage and mandibular growth velocity against the 
alternative hypothesis of a correlation. 
There is no correlation between mandibular and statural height growth velocities against the 
alternative hypothesis of a correlation. 
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Chapter 7: Methods and Participants 
7.1 Design 
This was a prospective, longitudinal observational cohort study investigating the correlation 
between cervical vertebral maturation, statural height and mandibular length of treated 
orthodontic patients. 
7.2 Method 
Participants were recruited into the study during the early stages of their orthodontic 
treatment. Routine orthodontic clinical records were collected from all patients as per the 
departmental protocol and used for treatment planning (see Figure 7.1). These records 
included taking the patients’ initial standing height and obtaining a lateral cephalogram 
radiograph. Following this, patients started orthodontic treatment, as appropriate, to correct 
their malocclusion.  
Routine care was provided as per the consultants’ treatment plan. Interim and final records 
were obtained as clinically necessary.  
In addition to this routinely acquired information, it was planned that the operator would take 
a measurement of standing height at each visit and record it in the clinical records.  
.
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7.1 Table of Study Steps and Data Collection 
*Standing height was measured with the patient barefoot, and in natural head position (Frankfort plane parallel with the ground) at every visit 
and in conjunction with national guidelines.69  
 
Table 7.1: Table of Study Steps
Study Steps Start records Treatment planning 
Each 
treatment 
appointment 
Post 
functional 
treatment 
Pre finish 
records 
Post debond 
records 
Patient information and informed consent X X     
Study models X X  X X X 
Extra-oral photographs X X  X  X 
Intra-oral photographs X X X X X X 
Lateral Cephalogram (as clinically required) X   X X  
Dental panoramic tomograph (as clinically 
required) X      
Intra-oral radiographs (as clinically required) X      
Standing height* X X X X X X 
23/10/2015 FINAL 
52 | P a g e  
 
7.4 Sample 
7.4.1 Participant Selection 
All participants were contacted to start orthodontic treatment having been on the waiting list 
at Liverpool University Dental Hospital and having been assessed as being suitable for 
treatment under the NHS criteria for care.  At their first appointment, routine history, 
examination and special investigations were undertaken after which the patient and their 
parent/guardian were informed about the study and invited to participate. All patients 
underwent standard assessment, orthodontic diagnosis and treatment planning.  
At their second appointment, the patients’ treatment plan was discussed and consent to 
participate in the study was obtained from willing participants and their parents/guardians. 
7.4.2 Inclusion criteria 
Participants were included if they: 
 Were between the ages of 8-18 years, 
 Were of either gender, male or female 
 Had not had previous orthodontic treatment, 
 Had commenced treatment with first year StRs in the academic year 2012-2013, 
 They and their parent/guardian had given informed consent/assent to participate in 
the study. 
7.4.3 Exclusion criteria  
Participants were excluded if they: 
 Were over the 18 years of age threshold at the start treatment “records” appointment. 
 Had previously recieved orthodontic treatment. 
 Had been diagnosed with any congenital clefts of the lip or palate, or known or 
suspected craniofacial syndromes or growth related conditions. 
 Did not consent to take part in the study. 
7.4.4 Measurements used 
7.4.4.1: Standing height 
It was planned that standing height would be measured in barefoot, with the patient in 
natural head position (Frankfort plane parallel with the ground) at every visit and in 
conjunction with national guidelines,69 and recorded and stored in the patients’ notes. It was 
measured using a wall mounted stadiometer. 
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Taking the standing height at each visit (every 6-weeks) was the only intervention that was in 
addition to routine clinical practice. It took approximately 5 minutes at the start of each 
appointment. It was carried out by the treating StR in a designated area, on route between 
the waiting room and the clinic. The height was recorded on a data sheet in the patients’ 
notes. 
7.4.4.2: Cephalometric measurements 
Lateral cephalograms (which include the cervical vertebrae) were taken: 
1. At the start of treatment, 
2. On completion of post functional appliance therapy (if undertaken) 
3. Prior to debond and completion of active intervention (as required). 
Lateral cephalograms were traced and analysed by hand.  A random 10% sample was 
retraced to assess the method error and reproducibility.  To ensure the data were 
comparable with previous research, the following cephalometric variables were included 
(Figure 7.2): 
 Measurements of mandibular size (Co-Gn, Co-Go, Go-Gn). 
 
Figure 7.2 – Cephalometric landmarks and measurements. Adapted from Franchi et 
al.20 
7.4.5 Consent 
Originally, one participant information leaflet and one participant consent form were 
designed for the study; however, the child assent form was produced after attending the 
research ethics meeting to obtain ethical approval for the study. 
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The local research ethics committee commented that the participant information leaflet (PIL) 
and consent form may be too difficult for 8-12 year olds to comprehend. In response to this, 
a new combined information and assent form was written for the younger participants using 
simple language and pictures demonstrating the action of measuring heights. Readability 
scores and text statistics were calculated for the original participant information leaflet and 
for the new assent form using an online tool.96 The scores of both PILs are reported in the 
results chapter. 
All participants were provided with information to aid their decision-making that explained 
both the risks and benefits of orthodontic treatment and participation in the study, as part of 
the informed consent process. All participants were aged between the ages of 8 and18 
years.  For those participants over 16 or deemed ‘Gillick competent’ consent was obtained 
from the participant. The participant information leaflet and consent form are attached in 
Appendices 1 and 2. For those participants under the age of 16 years and not deemed 
"Gillick competent", consent was obtained from a person of parental responsibility 
(Appendices 3 and 4) and assent was obtained from the participant (Appendix 5).  Informed 
consent was sought from patients as soon as was reasonably possible after ethical approval 
for the study had been obtained. A participant information leaflet, describing the study and 
participants involvement, supplemented the two-stage consent/assent process. 
7.4.6 Sample Size 
Data were analysed using multiple regression analysis, with CVM stage as a categorical 
predictor (independent variable), and the velocity of height change as the outcome 
(dependent) variable. Initially, the sample size was calculated so that if the CVM stage 
explained at least 7% of the variation in the outcome variable, then a sample size of 164 
would allow us to detect a relationship between the predictor and outcome with 80% power 
at the 95% confidence level. 
The sample size was revised based on an interim analysis of collected data, blinded to CVM 
stage. The standard deviation of the annualised growth velocity was estimated as 5.30cm/yr. 
For analysis, patients were grouped into 4 categories, CVM stages 1-2, 3, 4 and 5-6. Franchi 
et al20 observed growth velocities of approximately 5.5cm/yr, 8.7cm/yr, 5.0cm/yr and 
3.4cm/yr in patients starting treatment at these stages. To detect differences between these 
groups of the magnitude observed in Franchi et al20 with 80% power at the 5% significance 
level, 17 patients per group would be needed. Therefore the total sample size required was 
17 x 4= 68. 
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7.4.7 Radiograph Exposure 
At Liverpool University Dental Hospital, the site for the research study, written procedures 
that meet the requirements of the Ionising Radiation (Medical Exposure) Regulations 2000 
(IRMER)82 are in place and local IRMER protocols were followed. All participants underwent 
radiographic exposure in line with normal clinical practice. Therefore, there was no additional 
exposure. An expert opinion was sought from Paul Nixon, Consultant in Dental Radiology 
and Paul Charnock, a medical physics expert who both approved the use of radiographs and 
declared that the exposure to ionising radiation was reasonable and that the risks were 
adequately described in the participant and parent information leaflets. In addition, the 
research ethics committee approved these exposures. 
Effective doses and risks for dental examinations are given in Table 7.2 below. This 
information was taken from the EC publication RP 136 ‘European guidelines in dental 
radiology – the safe use of radiographs in dental practice’,129 but has also been confirmed as 
appropriate via local output information from the dental units onsite. The data are for adult 
patients and so assumes a worst-case subject of age 18. 
 
Procedure No of 
procedures 
Estimated procedure dose 
(National diagnostic reference 
levels) 
Risk of fatal 
cancer (per 
million) 
Lateral 
Cephalogram 
1-2 2-3 microsieverts per radiograph 
(routine for orthodontic treatment) 
0.34 
OPG 1-2 8 microsieverts per radiograph 
(routine for orthodontic treatment) 
0.21-1.9 
Intra oral 
Radiograph 
1 8 microsieverts per radiograph (will 
only be taken if clinically necessary, 
not routine) 
0.02-0.6 
Table 7.2: Ionising Radiation for different radiographs and corresponding risk of fatal 
cancer 
The ‘worst-case’ patient could have 2 each of panoramic and cephalographic examinations 
with 1 intra-oral examination. This would result in a typical whole body effective dose of 
about 30 microsieverts. This equates to an additional risk of fatal cancer of about 1 in 
350,000 and is equivalent to the natural background radiation received by members of the 
public on average during about 1 week. 
It is reiterated that all examinations were part of standard care and patients who were not 
participants in this research study, would also be subject to this level of radiation. 
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7.4.8 Treatment stopping 
All patients were assessed regarding their potential compliance before commencing 
treatment.  However, treatment may have been stopped if the patient failed to comply with 
attendance at appointments or reached a stage where they compromised the health of their 
teeth/ gums and the benefits of treatment were outweighed by the consequences. 
7.5 Statistics 
Statistical support was sought from Dr G. Burnside. 
7.5.1 Assessing the validity of CVM staging to predict growth velocity 
Data were analysed using multiple regression analysis, with CVM stage as a categorical 
predictor (independent variable), and height change velocity as the outcome (dependent) 
variable. The sample size calculation has been described in section 7.4.6. 
7.5.2 Cephalometric Method Error 
Two methods were used to assess intra-examiner reliability of the lateral cephalograms 
tracing. The cephalometric tracing error was firstly calculated using Dahlberg’s formula: 
 
This allowed the calculation of the method error on a random 10% sample of cephalograms.  
Dahlberg’s d is the S.D. of the sample of double determinations, not the average difference.  
This is a measure of the variability, both random and systematic, due to technical 
inconsistencies. It is assumed that this value is the same for all specimens and by selecting 
cases at random to re-measure, it is assumed that the estimate of method error can be 
extrapolated to the whole sample. 
The second method was the British Standards Institution Coefficient of Repeatability (CR) 
formula advocated by Bland and Altman.130 This works on the assumption that the mean 
difference between two repeated measurements should be zero (if there is large differences 
between the measurements this method cannot be used). The standard deviation of the 
differences is measured and if the differences in the measurements lie within two standard 
deviations for greater than 95% of cases then there is adequate repeatability.131 
7.6 Ethics and Regulatory Approvals 
The study was conducted in compliance with the principles of the Declaration of Helsinki 
(1996), the principles of GCP and in accordance with all applicable regulatory requirements 
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including but not limited to, the Research Governance Framework and the Medicines for 
Human Use (Clinical Trial) Regulations 2004, as amended in 2006 and any subsequent 
amendments. 
This protocol and related documents were submitted for review to Liverpool Children’s 
Research Ethics Committee (REC). Amendments were requested to the child information 
sheet and consent form, which were carried out and submitted. Ethical approval was granted 
from the Liverpool East Research Ethics Committee, reference number 13/NW/0408 based 
on protocol number UoL000751; Amendment number 1. This was granted on 30th October 
2013. 
Annual progress and safety reports and a final report at conclusion of the study were 
submitted to the sponsor and the REC within the timelines defined in the Regulations. 
7.7 Direct Access to Source Data and Documents 
The Investigator(s) permitted study-related monitoring, audits, REC review and regulatory 
inspections (where appropriate) by providing direct access to source data and other 
documents (i.e. patients’ case sheets, X-ray reports etc).  
7.7.1 Data Handling 
The Chief Investigator (JEH) is acting as custodian for the study data.  The following 
guidelines were strictly adhered to: 
All data were collected on a standardised and pseudo-anonymised data collection sheet 
(Appendix 6). This was kept in the notes of the patient, which were kept in the same records 
collection area as was usual for all patients undergoing treatment in the orthodontic 
department.  
Any data stored outside the clinical records, was pseudo-anonymised by the allocation of a 
study identifier. The code for the identifier stored in a locked separate location (SH office). 
Any radiographic images used were fully anonymised. 
All anonymised data were stored on a password-protected computer and all analysis 
paperwork was kept in a locked drawer in the investigators office, which had a key padlock 
and was locked at all times. 
All study data was stored and archived in line with the Medicines for Human Use (Clinical 
Trials) Amended Regulations 2006 as defined in the Joint Clinical Trials Office Archiving 
SOP. After the study has ended, pseudonymised data will be stored on a hospital Trust 
computer, by the chief investigator, JEH, which will be password protected for 5 years. 
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7.8 Quality Assurance 
Monitoring of this study will be to ensure compliance with Good Clinical Practice and 
scientific integrity, was managed and oversight retained; by the Co-sponsors 
(University/Trust). 
7.9 Publication Policy 
It is intended that the results of the study will be reported and disseminated at international 
conferences and in peer-reviewed scientific journals.  The information also forms part of a 
research thesis submitted in partial fulfilment of a DDSc at the University of Liverpool. 
7.10 Financial Aspects 
Small monies were sought from the DDSc research fund (Orthodontic Department) that were 
used to buy appropriate stationary for the patient information leaflets, and consent/assent 
forms. 
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Chapter 8: Summary of Participant Procedures 
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Chapter 9: Results 
9.1 General Characteristics 
Patients who met the inclusion criteria and consented to taking part in the study had their 
first height measured when their initial records were taken or at the soonest appointment 
after. All initial heights were taken within a maximum of 6 months after the initial lateral 
cephalogram to ensure that the change in height velocity would reflect the CVM stage 
assessed on the cephalogram. 
Patients heights were then re-measured at every fixed adjust appointment over a 1 year 
period from the date of ethical approval to the 31st October 2014. Patients that required an 
additional lateral cephalogram (if it was clinically indicated) were included in the analysis of 
mandibular growth velocity between the two lateral cephalograms. A second cephalogram 
was only ordered if the radiograph was indicated clinically and never for the purpose of the 
research project only.  
Inter- and intra-observer reliability was assessed with regards to statural height 
measurement and CVM staging. The observers involved in statural height measurement 
were the 1st and 2nd year orthodontic StRs at Liverpool University Dental Hospital. CVM 
staging was carried out by observer SH. SH was calibrated to observer JH who had been 
calibrated to CVM images supplied by McNamara, the co-author of the CVM index.  
Intra-observer reliability (SH) was also assessed with regards to the three linear 
measurements that were used to calculate the area of the triangle formed between 
condylion, gnathion and gonion to calculate mandibular growth.  
Regarding the primary outcome, there was a statistically significant increase in statural 
height velocity at CVM stage 3 when compared to all the other CVM stages. The difference 
in mean annualised growth velocity was significant between all the CVM stages except 
between CVM stages 2 and 4.  
The amount of mandibular growth that occurred at each CVM stage was higher at stage 3 
and 4 than at stages 1, 2, 5 and 6 but due to the small sample size (n=36) this was not 
statistically significant. 
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9.2 Readability 
After recommendation from the Research Ethics committee to have a patient information 
leaflet and assent form for the younger age group of 8-12 years, a new PIL was developed 
with coloured illustrations and improved readability. The readability tests that were applied to 
assess the ease of reading included, as discussed in the literature review; the Flesch-
Kincaid Reading Ease score, the Flesch-Kincaid Grade level, the Gunning-Fog score, the 
SMOG Index, the Automated Readability Index and the Average Grade Level. 
This demonstrated a large change in the readability ease with the average grade level falling 
from 7.1 to 4.0. A grade level (based on the American school system) is equivalent to the 
number of years of education a person has had. The Flesch-Kinaid reading ease score 
increased from 70.6 to 91.6. A higher score indicates easier readability; scores usually range 
between 0 and 100. 
Text Statistics Old Information Sheet New Assent Form 
Character Count 2,741 1,689 
Syllable Count 902 554 
Word Count 623 449 
Sentence Count 46 42 
Characters per word 4.4 3.8 
Syllables per word 1.4 1.2 
Words per sentence 13.5 10.7 
Table 9.1: Text statistics 
The calculation of text statistics (Table 9.1) allows the measurement of readability ease 
using common scoring systems that have described below. This allows the identification of 
any issues with content readability particularly important in the context of obtaining assent to 
participate in a research study. It has been shown that a patient’s overall satisfaction with 
their treatment and clinician increases when they understand the information that they have 
been given.132 
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Readability Formula Old Information Sheet New Assent Form 
Flesch-Kincaid 
Reading Ease 70.6 91.6 
Flesch-Kincaid Grade 
Level 6.8 3.1 
Gunning-Fog Score 8.1 5.3 
SMOG Index 6.9 3.5 
Automated Readability 
Index 6.1 1.6 
Average Grade Level 7.6 4.0 
Table 9.2: Readability Scores 
In summary, all of the readability scores showed a marked improvement when comparing 
the original participant information leaflet and the new assent form.  The Flesch-Kincaid 
Grade level with the new assent form was 3.1; this should have been understandable to the 
youngest patients in our sample. The newly written assent form had a Gunning-Fog index of 
5.3, which was a reduction of 2.8 points. The Automated readability index in the new assent 
form reduced to 1.6 from 6.1. The REC confirmed approval of the changes to the consent 
form and information leaflet and ethical approval for the study was obtained with the 
reference number 13/NW/0408 based on protocol number UoL000751 amendment number 
1. This was granted on 30th October 2013. 
 
9.3 Reliability 
The intra-observer reliability of the CVM index was calculated by construction of a 6x6 table 
as shown in Table 9.3. These data were entered into the StatsDirect App to calculate the 
linear weighted kappa. 
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CVM STAGE AT PHASE I TOTAL 
 
CVM 
STAGE 
AT 
PHASE 
II 
 1 2 3 4 5 6  
1 7      7 
2 
 14     14 
3 
  10    10 
4 
   19   19 
5 
    21  21 
6 
     10 10 
TOTAL  7 14 10 19 21 10 81 
Table 9.3: 6 x 6 Table for calculating Kappa scores: Example used for SH inter-
observer agreement staging LUDH and McNamara’s ideal cephalograms 
CVM Stage 1 2 3 4 5 6 
1 1 0.96 0.84 0.64 0.36 0 
2 0.96 1 0.96 0.84 0.64 0.36 
3 0.84 0.96 1 0.96 0.84 0.64 
4 0.64 0.84 0.96 1 0.96 0.84 
5 0.36 0.64 0.84 0.96 1 0.96 
6 0 0.36 0.64 0.84 0.96 1 
Table 9.4: Cohens Kappa (weighted by 1-[(i-j)/(1-k)]²). Ratings weighted by scale 
shown. 
The weightings shown in Table 9.4 were used to assess the kappa value. The reason for 
using this weighting is explored in the literature review and exploration of using other 
weightings is assessed in the discussion chapter. 
9.3.1: Intra-observer Reliability of CVM Index 
The intra-observer agreement for observer SH for the consecutive image sample from LUDH 
was ‘perfect agreement’ with 100% agreement, κw 1 SE (0.11). The intra-observer 
agreement for SH for the ideal sample was also ‘perfect agreement’ with 100% agreement, 
κw 1 SE (0.33) (Table 9.5). 
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Linear weighting 
INTRA-OBSERVER 
AGREEMENT 
 % 
Agreement 
Κw S.E. 95%CI 
(OBSERVER SH) 
LUDH 
SAMPLE 
(72) 
100 1 0.11 0.76-1.23 
IDEAL 
SAMPLE  
(9) 
100 1 0.33 0.34-1.65 
Table 9.5: Weighted intra-observer reliability for CVM staging  
9.3.2: Inter-observer Reliability of CVM Index 
When observers SH and JH were compared, the inter-observer agreement was ‘almost 
perfect’. The agreement was 97.4% with the LUDH sample (ΚW 0.83) and 99.3% agreement 
with the ideal image sample. (ΚW 0.96) (Table 9.6). 
 
Linear weighting 
INTER-OBSERVER  
AGREEMENT 
 
% 
Agreement 
Κw S.E. 95%CI 
OBSERVERS 
SH & JH 
LUDH 
SAMPLE 
(72) 
97.4 0.83 0.11 0.61-1.07 
IDEAL 
SAMPLE 
(9) 
99.3 0.96 0.32 0.32-1.61 
Table 9.6: Inter-observer reliability of CVM index (SH and JH) 
9.3.3: Validation of the McNamara CVM teaching method  
The ideal image sample was provided by the co-author of the index, Professor J McNamara 
and each image represented a distinct CVM stage.  Assessing the agreement between the 
observers when they applied the index to the ideal image sample was used to validate the 
CVM teaching method described by McNamara.  The agreement with this sample was 
overall ‘almost perfect’. The intra-observer agreement was 100%, Κw1 SE (0.33) (SH).  The 
inter-observer agreement was 99.3%, Κw0.96 SE (0.32) (SH and JH).  The high level of 
agreement with the ideal image sample suggests that observers were able to apply the CVM 
staging method in the way it was intended.   
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9.3.4: Calibration of LUDH researchers SH and JH as CVM experts  
In order for SH to be calibrated in this method of CVM staging, SH was calibrated against a 
sample of lateral cephalograms that had been used in previous research looking at the 
reliability of the CVM method.27 In Rainey’s reliability study, mutually agreed CVM stages for 
each radiograph in a sample from LUDH was compared to the CVM stage determined by the 
authors of the index, Dr. J McNamara and Dr. L Franchi. The overall agreement between the 
2 results was ‘substantial’   93% Κw0.78 SE (0.03).  The upper limit of the 95% confidence 
interval fell in the ‘perfect agreement’ category.  This confirmed the LUDH researchers had 
an acceptable level of agreement with the authors of the index to be awarded ‘expert’ status.   
The same sample was used to calibrate SH and her reliability using this method. The overall 
agreement with JH was 97.4% Κw0.83, falling within the ‘perfect agreement category’ thus 
establishing researcher SH as calibrated in using the method. 
9.3.5: Reliability of Height Measurement 
To determine the reliability of the 8 registrars taking the standing height measurements, all 8 
observers measured 20 members of staff from the orthodontic department on two occasions 
6 weeks apart. The height measurements took place at the same time of day (morning) on 
the same week day on both occasions as it has been documented that people’s statural 
height changes depending on the time of day and day of the week.133  
The order that people were measured was randomised using a computer-generated list 
(generated by JEH) in an attempt to reduce bias. The observers were blinded to each other’s 
measurements to reduce any bias. Both intra-class correlation coefficients and Bland and 
Altman plots were used to assess intra- and inter-observer agreement. 
9.3.6: Intra-observer Reliability of Statural Height Measurement 
SH 
The intra-class correlation coefficient (one way random effects) was 0.994 (SD=0.54), which 
as classed as excellent agreement. This is demonstrated in Figure 9.1. 
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Figure 9.1: Bland and Altman Plot for SH intra-observer agreement for standing height 
measurement; Mean difference: 0.34, Limits of agreement: -1.05 - 1.73. 
 
Statistics Intra-class 
correlation 
coefficient (ICC) 
Mean Difference Limit of agreement 
StR 
SH 0.994 0.34 -1.05, 1.73 
StR 1 0.996 0.32 -0.85, 1.49 
StR 2 0.993 0.51 -0.77, 1.79 
StR 3 0.993 0.53 -0.72, 1.77 
StR 4 0.994 0.18 -1.13, 1.50 
StR 5 0.997 0.22 -0.79, 1.23 
StR 6 0.995 0.13 -1.43, 1.69 
StR 7 0.994 0.45 -0.83, 1.73 
 
Table 9.7: Table to summarise all StRs results for reliability of statural height 
measurements including intra-class correlation coefficient (one way random effects) 
for inter-observer agreement as well as the mean difference and limits of agreements 
from the Bland and Altman Plots for intra-observer agreement for standing height 
measurement. 
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9.3.7: Inter-observer Reliability of Statural Height Measurement 
Phase 1: First stage calibration of StRs for measurement of statural height 
The intra-class correlation coefficient (one way random effects) for inter-observer agreement 
of standing height measurements was 0.986, which is classed as excellent. This is displayed 
in an agreement plot in Figure 9.2. 
Agreement Plot
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Figure 9.2: Bland and Altman Plot for inter-observer agreement for standing height 
measurement at Phase 1 
Phase 2: Second stage of calibration of StRs for statural height measurements 
The intra-class correlation coefficient (one way random effects) for inter-observer agreement 
of standing height measurements was 0.997, which is classed as excellent. This is displayed 
in an agreement plot in Figure 9.3. 
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Figure 9.3: Bland and Altman Plot for inter-observer agreement for standing height 
measurement at phase 2 
9.3.8: Intra-observer Reliability of Cephalometric Measurements 
To assess the reliability of cephalometric measurements, observer SH measured 20 
cephalograms 6 weeks apart. The 20 lateral cephalograms used to assess the reliability 
were selected at random by JEH from an original sample of 130 lateral cephalograms using 
a computer generated randomised sequence in an attempt to reduce selection bias. 
Lines condylion-gonion, gonion-gnathian and gnathian-condylion were measured on these 
20 radiographs, as they were used to calculate the area of the triangle made by these three 
landmarks to assess mandibular size. The rationale for using these landmarks to assess 
mandibular growth was explored in the literature review. 
9.3.8.1 Intra-observer Reliability of Condylion-Gonion  
Condylion – Gonion Agreement   
The Intra-class correlation coefficient (one way random effects) was 0.93 (SD 0.17), which 
is classed as excellent. Agreement was also plotted on a Bland and Altman plot (Figure 
9.4) 
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Agreement Plot (95% limits of agreement)
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Figure 9.4: Bland and Altman Plot for SH intra-observer agreement for condylion-
gonion linear measurement, 95% Limits of agreement = -0.46 to 0.52 
9.3.8.2 Intra-observer Reliability of Gonion-Gnathion  
The intra-class correlation coefficient (one way random effects) was 0.93 (SD 0.12), which is 
classed as excellent. Agreement was also plotted on a Bland and Altman plot (Figure 9.5) 
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Figure 9.5: Bland and Altman Plot for SH intra-observer agreement for gonion-
gnathion linear measurement, 95% Limits of agreement = -0.33 to 0.35 
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9.3.8.3 Intra-observer Reliability of Gnathion - Condylion 
The intra-class correlation coefficient (one way random effects) was 0.85 (SD 0.31) which 
although lower than the other 2 linear measurements is still classed as excellent. Agreement 
was also plotted on a Bland and Altman plot (Figure 9.6). 
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Figure 9.6: Bland and Altman Plot for SH intra-observer agreement for gnathion-
condylion linear measurement, 95% Limits of agreement = -0.69 to 0.97 
9.4: Descriptive Statistics of Sample 
The total number of patients recruited into the study was 185. In the process of data 
collection, 6 patients had to be excluded due to the second, third and fourth vertebrae not all 
being visible on the radiograph. This is a potential problem with using the CVM index that 
had been identified previously and will be examined further in the discussion section.  
Only one height measurement had been recorded for 26 patients, and thus, these patients 
had to be excluded from the study, as no annualized growth velocity could be calculated. 
This problem stemmed from data collection and despite frequent reminders to those taking 
part in the study, not all were diligent in taking the height measurements for their patients. 
The inclusion criteria included patients of age 8-18 years, so 4 patients had to be excluded 
from the study, as they were aged 19-30 years old. It is interesting to note that no patients 
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were excluded for being too young, but this is probably a reflection of the population that 
were most commonly treated. 
On collating the data, it emerged that some patients had not had their standing height 
measured at the time of their first cephalometric radiograph. This was not seen to be a 
problem if the first height was measured a few months after the radiograph. However, there 
were a number of patients where the first height was recorded 2 years after the initial lateral 
cephalogram. On discussion it was felt that these had to be excluded from the data analysis 
as the height change 2 years after the cephalogram may not reflect the CVM stage recorded 
on the cephalogram. With this in mind, any patients who had not had their heights measured 
within 6 months of having their initial lateral cephalogram taken were excluded from the final 
analysis, which caused a further 41 patients to be excluded. Thus, the final sample size that 
could be used in the data analysis was 108. This is demonstrated in Figure 9.7, which shows 
the flow of patients through the study. 
23/10/2015 FINAL 
72 | P a g e  
 
 
Figure 9.7: Flow diagram of participants in study 
The mean age in the final sample (n=108) was 13.9 years (SD=1.7) (Table 9.8) and ranged 
from 10.16 years to 18.56 years. The age distribution was normal as shown in Figure 9.8. 
 Number 
of 
Patients 
Mean Minimum Maximum 95% CI Standard 
Deviation 
Lower 
Bound 
Upper 
Bound 
Age 
(years) 
108 13.97 10.16 18.56 13.64 14.30 1.7 
 
Table 9.8: Mean age and age range of study participants. 
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Figure 9.8: Age distribution of patients included in final analysis 
There were 60 females (56%) and 48 males (44%) in the final sample (Table 9.9). The mean 
age within the females was 13.5 years (age range 10.16-17.35 years SD 1.6). The mean 
age in the males was 14.5 years (age range 11.8-18.56 years SD 1.6). As the difference 
between the males and females was not significant, they were analysed together. 
Gender Number 
of 
Patients 
Mean Standard 
Deviation 
Minimum Maximum 95%CI 
Lower 
Bound 
Upper 
Bound 
Female 60 13.51 1.62 10.16 17.35 13.10 13.93 
Male 48 14.53 1.64 11.80 18.56 14.06 14.22 
Total 108 13.97 1.70 10.16 18.56 13.64 14.30 
Table 9.9: Table to show breakdown of males and females and their age distribution 
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In order to have enough patients in each group to demonstrate enough power to show a 
statistically significant difference, patients at CVM stages 1 and 2 were combined and CVM 
stage 5 and 6 were combined. In addition, it is the middle stages that are of particular 
interest for the purpose of this research. 
When the patients who had not had their height recorded within 6 months of their lateral 
cephalogram being taken were excluded, this excluded a further 41 patients from the 
participants that were eligible to be included in the analysis. 
Table 9.10 shows the number of patients at each CVM stage. The group with the highest 
number of patients was CVM stage 5 followed by 4. The groups with the lowest frequencies 
were CVM stage 1 followed by CVM stage 6. 
CVM stage Number of patients Percentage Cumulative 
Percentage 
1 1 0.9 0.9 
2 13 12.0 13.0 
3 22 20.4 33.3 
4 33 30.6 63.9 
5 34 31.5 95.4 
6 5 4.6 100.0 
Total 108 100.0  
 Table 9.10: Number and Percentage of patients in final sample at each CVM stage  
When the patients at CVM stages 1 and 2 and stages 5 and 6 were combined the new 
frequencies at each stage are shown in Table 9.11. The sample size required to give 
adequate power was reached in all the groups except group CVM stage 1 and 2 which had 3 
participants fewer than the target sample size of 17. 
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CVM Stage Number of Patients Percentage Cumulative 
Percentage 
1 & 2 14 13.0 13.0 
3 22 20.3 33.3 
4 33 30.6 63.9 
5 & 6 39 36.1 100.0 
Total 108 100.0 
 
Table 9.11: Number and Percentage of patients in final sample at each stage, when 
CVM stages 1&2 and 5&6 combined 
It is interesting to note the distribution of males and females at each CVM stage (Table 
9.12). It has been documented previously that females reach puberty prior to males and this 
is reflected in this sample. A much higher proportion of the females were at CVM stage 4 
and 5, whereas a larger proportion of the males are at CVM stage 3 and 4 within this 
particular snapshot in time. 
Gender CVM Stage  
 1 2 3 4 5 6 Total 
Female No. 0 9 8 17 24 2 60 
% 0 15 13 28 40 3  
Male No. 1 4 14 16 10 3 48 
% 2 8 29 33 21 6  
Total No. 1 13 22 33 34 5 108 
% 1 12 20 31 31 5  
Table 9.12: Number and Percentage of patients at each CVM stage broken down in to 
male and female 
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9.5: CVM Stage and Statural Height Velocity 
For ease the group combining CVM stages 1 and 2 will be referred to as Stage 2. The group 
combining CVM stages 5 and 6 will be referred to as Stage 5.  (Stage 3 represents CVM 
stage 3 and stage 4 represents CVM stage 4). 
Table 9.13 shows the mean annualised growth velocity (MAGV) in centimetres per year 
(cmy-1) in each CVM group. There was an increase in the MAGV from stage 2 to stage 3 by 
almost 5cm. The MAGV then drops by 4.3cm at CVM stage 4 relative to CVM stage 3. At 
stage 5, the MAGV drops further by 3.5cm to 1.5cm MAGV. This pattern would support the 
idea that standing height velocity is greatest at CVM stage 3. 
CVM Stage 
Mean annualized 
growth rate (cmy-1) Number of patients Standard deviation 
1 & 2 4.51 14 2.71 
3 9.39 22 4.44 
4 5.00 33 2.33 
5 & 6 1.56 39 2.34 
Overall/Total 4.59 108 4.06 
Table 9.13: Mean annualised growth velocity by CVM stage 
The trend in MAGV through the CVM stages is displayed in Figure 9.9. This demonstrates 
the increase in MAGV that occurs at CVM stage 3. The growth velocity then decreases at 
CVM stage 4 from CVM stage 3, and further reduces going into CVM stage 5 and 6. There 
were 2 outliers in the CVM stage 3 group who showed a particularly high rate of growth. 
There are also 3 outliers at CVM group 5 and 6, which suggests that there were individuals 
who displayed some late growth. 
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Figure 9.9: Box plot of mean annualised growth velocity MAGV at different CVM 
stages 
When assesing the MAGV split between gender (Tables 9.14, 9.15), the same pattern is 
seen as described above with the MAGV highest at CVM stage 3 and decelerating towards 
CVM stage 5. However, males’ growth velocities were generally higher than females and 
their peak growth velocity was 10.4cmy-1 (95%CI: 7.68, 13.30) MAGV compared to only 
7.5cmy-1 (95%CI: 4.83, 10.26) MAGV for girls; but this difference was not statistically 
significant in our sample (p=0.36). 
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CVM Stage Mean annualized growth rate (cmy-1) 
Number 
of 
patients 
Standard 
deviation 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
1 & 2 3.87 9 2.16 2.21 5.53 
3 7.54 8 3.25 4.83 10.26 
4 4.43 17 2.20 3.31 5.57 
5 & 6 1.77 26 2.70 0.68 2.86 
Overall /Total 3.61 60 3.17 
  
Table 9.14: Mean annualised growth velocity at each CVM group for Females 
CVM Stage Mean annualized growth rate (cmy-1) 
Number 
of 
patients 
Standard 
deviation 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
1 & 2 5.65 5 3.47 1.34 9.96 
3 10.44 14 4.79 7.68 13.20 
4 5.60 16 2.38 4.33 6.87 
5 & 6 1.13 13 1.39 0.29 1.97 
Total 5.81 48 4.70 
  
Table 9.15: Mean annualised growth velocity at each CVM group for Males 
Table 9.16 shows the mean age at each CVM stage. The difference between the ages at 
each CVM stage was not signifiant except for between stages 5/6 and all the other CVM 
stages.  
When females and males were looked at separtely, the same pattern was found, that the 
difference in age between stages 1-2, 3 and 4 were not significant; however, the difference 
between stages 5 and 6 and the other stages was significant. 
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CVM Stage Mean age (yrs) Standard 
deviation 
95% Confidence Interval 
Lower Bound  Upper Bound 
1 & 2 12.71 1.22 12.01 13.41 
3 13.15 1.12 12.65 13.65 
4 13.55 1.57 13.00 14.11 
5 & 6 15.23 1.45 14.76 15.70 
Table 9.16: Average age in years at each CVM stage  
The mean age of females at CVM stage 3 was 12.4 (SD 1.4) years whereas males were an 
average age of 13.5 (SD 0.9) years when they were at CVM stage 3 as shown in Table 9.17. 
This confirms previous research reporting that females reach puberty prior to males and the 
difference was significant [-1.20cm (95%CI -2.12, -0.28)].20 
Gender 
Number 
of 
Patients 
Mean 
Age 
(years) 
Minimum Maximum 
95%CI 
Standard 
Deviation Lower 
Bound 
Upper 
Bound 
Female 8 12.4 10.55 13.61 11.46 13.36 1.14 
Male 14 13.6 11.80 14.51 13.06 14.09 0.90 
Total 22 13.2 10.55 14.51 12.65 13.65 1.12 
Table 9.17: Average age of males and females at CVM stage 3 
ANOVA was used to test for statistically significant differences in the MAGV between the 
different CVM stages. The null hypothesis stating that there was no difference between the 4 
groups was rejected, with the differences being statistically significant to a p-value of 0.0001 
(Table 9.18). 
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Sum of 
squares 
df Mean 
Square 
F Sig 
Between 
Groups 
869.662 3 289.887 33.812 0.0001 
Within 
Groups 
891.657 104 8.574   
Total 1761.319 107    
Table 9.18: ANOVA results testing null hypothesis of no difference between the 4 CVM 
stage groups with regards to MAGV was rejected. The P-value of 0.0001 suggests 
there was a significant difference between the MAGV of patients at different CVM 
stages. 
Pairwise comparisons were then carried out (Table 9.19) to look at each stage relative to 
every other stage and look for statistically significant differences. 
Firstly starting with CVM Stage 2, there was a statistically significant difference from Stage 3 
with Stage 2 being on average 4.88cmyr-1 less (p=0.001, 95%CI 2.26;7.49). There is also a 
statistically significant reduction (of 2.9cmyr-1) in MAGV between Stage 2 and Stage 5 
(p=0.001, 95%CI 0.56;5.32). However, the difference in MAGV between Stage 2 and Stage 
4 was not statistically significant.   
Looking at CVM Stage 3, the MAGV at CVM Stage 3 was significantly higher than the MAGV 
at all the other stages. The difference between Stage 3 and Stages 2 and 4 were very similar 
(4.88cmyr-1 and 4.38cmyr-1) whereas the difference between Stage 3 and Stage 5 was 
slightly larger with the MAGV at Stage 3 being on average 7.8cmyr-1 higher than the MAGV 
at Stage 5. 
Looking at CVM Stage 4 compared to the other stages, there was no significant difference 
between the MAGV at Stage 2 and Stage 4. The MAGV at Stage 3 was an average of 
4.4cmyr-1 higher than at Stage 4 (p=0.0001, 95%CI 2.28;6.49). The MAGV at Stage 5 was 
an average of 3.4cmyr-1 lower than at Stage 4 (p=0.001, 95%CI 1.63;5.25). 
Looking at Stage 5, the MAGV was significantly lower at this stage than any other group, but 
particularly lower than the MAGV at Stage 3 (a difference of 7.8cmyr-1  (p=0.001, 95%CI 
5.79;9.86). 
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CVM 
Stage (A) 
CVM 
Stage (B) 
Mean 
Difference 
(A-B) 
Std. Error Significance 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
2 3 
4 
5 
-4.88 
-4.97 
2.94 
1.00 
0.93 
0.91 
0.001* 
0.951 
0.009* 
-7.50 
-2.93 
0.56 
-2.27 
1.94 
5.33 
3 2 
4 
5 
4.88 
4.38 
7.83 
1.00 
0.81 
0.78 
0.001* 
0.001* 
0.001* 
2.27 
2.28 
5.79 
7.50 
6.49 
9.86 
4 2 
3 
4 
0.50 
-4.38 
3.44 
0.93 
0.81 
0.69 
0.951 
0.001* 
0.001* 
-1.94 
-6.49 
1.63 
2.94 
-2.28 
5.25 
5 2 
3 
4 
-2.94 
-7.83 
-3.44 
0.91 
0.78 
0.69 
0.009* 
0.001* 
0.001* 
-5.33 
-9.86 
-5.25 
-0.56 
-5.79 
-1.63 
*The mean difference is significant at the 0.05 level. 
Table 9.19: Pairwise comparisons of differences between stages. Dependant variable: 
Mean annualized growth velocity. Tukey HSD 
9.6: CVM Stage and Mandibular Growth Velocity 
The participants who had had two lateral cephalograms taken by the end date of the study 
were included in the analysis to determine velocity of mandibular growth. Table 9.20 shows 
the number of patients at each CVM stage at the time of their initial lateral cephalogram. 
There were a total of 36 participants who had 2 cephalograms taken. 
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CVM Stage Number of 
Patients 
Percentage Cumulative 
Percentage 
1 1 2.8 2.8 
2 4 11.1 13.9 
3 11 30.6 44.4 
4 8 22.2 66.7 
5 12 33.3 100 
Total 36 100  
Table 9.20: Number and Percentage of patients at each CVM stage 
Table 9.21 shows the frequencies in each category when Stages 1 and 2 and combined and 
Stages 5 and 6 were combined as done previously. Despite combining the first two and last 
two stages, the numbers in each group were not sufficient to detect any statistically 
significant differences despite some clear trends emerging. 
CVM Stage Number of 
patients 
Percentage Cumulative 
Percentage 
1 & 2 5 13.9 13.9 
3 11 30.6 44.4 
4 8 22.2 66.7 
5 & 6 12 33.3 100 
Total 36 100 
 
Table 9.21: Number and Percentage of patients at each CVM group when CVM stages 
1 and 2 and CVM stages 5 and 6 were combined 
Table 9.22 shows the change in the area of the triangle formed by Go-Co-Gn annualised so 
that the velocity of growth is standardised and can be compared between stages. The 
mandibular growth velocity was the lowest in stage 2 (0.19cm2) followed by stage 5 
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(0.26cm2) followed by stage 4 (0.446cm2) with the highest growth velocity at stage 3 
(0.448cm2).  
All the linear measurements (Co-Go, Go-Gn, Gn-Co) showed a similar pattern with stage 3 
showing the highest velocity of growth, closely followed by stage 4. The velocity of growth is 
higher at stage 5 than stage 2 for line gonion-condylion. However, it was the converse with 
both condylion-gnathion and gonion-gnathion where the growth velocity was lowest at stage 
5 followed by stage 2. 
CVM Stage 
Area of 
Triangle 
Co-Go-Gn 
(cm2y-1) 
Condylion-
Gnathion 
(cmy-1) 
Gnathion-
Gonion 
(cmy-1) 
Gonion-
Condylion 
(cmy-1) 
1 & 2 
(N= 5) 
Mean 
Std. Deviation 
0.19 
0.24 
0.38 
0.32 
0.13 
0.12 
0.19 
0.25 
3 
(N= 11) 
Mean 
Std. Deviation 
0.45 
0.29 
0.54 
0.29 
0.17 
0.31 
0.45 
0.39 
4 
(N= 8) 
Mean 
Std. Deviation 
0.45 
0.37 
0.54 
0.28 
0.16 
0.32 
0.45 
0.37 
5 & 6 
(N= 12) 
Mean 
Std. Deviation 
0.26 
0.45 
0.26 
0.48 
0.08 
0.21 
0.26 
0.45 
Overall 
(N= 36) 
Mean 
Std. Deviation 
0.35 
0.39 
0.42 
0.38 
0.13 
0.25 
0.35 
0.39 
Table 9.22: Mean change in annualised area of triangle Co-Go-Gn, and linear 
measurements Co-Gn, Gn-Go, and Go-Co. 
An ANOVA statistical test was carried out to test for differences between the groups but 
none of the stages were shown to have a statistically significant difference in velocity of 
mandibular growth, due to the small numbers involved (Table 9.23). 
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Change per year Sum of 
Squares 
df Mean 
Square 
F Sig. 
Area of 
triangle Co-
Go-Gn 
Between groups 
Within Groups 
Overall 
0.41 
4.95 
5.35 
3 
32 
35 
0.14 
0.16 
0.87 0.47 
Condylion-
Gnathion 
Between groups 
Within Groups 
Overall 
0.58 
4.33 
4.91 
3 
32 
35 
0.19 
0.14 
1.43 0.25 
Gnathion-
Gonion 
Between groups 
Within Groups 
Overall 
0.06 
2.20 
2.26 
3 
32 
35 
0.02 
0.07 
0.29 0.84 
Gonion-
Condylion 
Between groups 
Within Groups 
Overall 
0.41 
4.95 
5.35 
3 
32 
35 
0.14 
0.16 
0.87 0.47 
Table 9.23: ANOVA testing null hypotheses of no difference between groups with 
regards to annualised mandibular growth velocity.  
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Chapter 10: Discussion 
 
Growth is such a fundamental concept in orthodontics, that it is not uncommon for the 
decision regarding timing or even modality of treatment to be influenced by the stage of 
growth and development of the patients.  
Peak growth velocity in standing height has been shown to be one of the most accurate 
methods of determining the overall skeletal growth velocity.13, 33 However, this is not useful to 
the orthodontist who can only assess the peak growth velocity in standing height 
retrospectively and it is of little assistance when it comes to assessing the remaining growth 
potential. In addition, this would require regular measurements of a patient’s standing height 
which is not practical because the orthodontist often doesn’t see the patient regularly at the 
appropriate stage, only seeing them as a new patient when referred by their dentist with a 
desire for orthodontic treatment. 
Assessment of the morphology of the cervical vertebrae, using various indices has been 
proposed as a method of identifying the timing of onset of the pubertal peak in skeletal 
growth, and estimates the proportion of growth remaining.16, 20, 26  However, no previous 
research has prospectively demonstrated a significant correlation between the CVM stage 
and standing height growth velocity in a contemporary sample of children and adolescents. 
The results of this research study have confirmed the findings of previous retrospective 
research based on historic samples. This has been contrary to the expectations of the 
primary researcher. This may have potentially significant clinical implications, which will be 
explored throughout the discussion chapter.  
10.1 Limitations of the study 
10.1.1 Ethical Approval 
Ethical approval took approximately one year to obtain which delayed the start of data 
collection and reduced the duration for which the study could run. Due to the restricted time 
period over which the research can be carried out due to it being tied to a 3 year DDSc 
programme, the delay in obtaining ethical approval meant that the data collection could only 
run for 1 year. There were many barriers to the smooth progress of the process of obtaining 
ethical approval for the study. 
 Despite the only intervention being the measurement of patients’ heights, a full ethical 
review was required including an interview with the Research Ethics Committee (REC). An 
expert opinion and risk report was required from both a consultant radiologist and a nuclear 
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physicist because radiographs were being assessed as part of the research. This was 
despite the fact that no radiographs were being taken for the purpose of the research. We 
were using radiographs that had already been taken as part of the patients’ treatment 
planning process and were only taken when clinically indicated and justifiable, but never for 
the purpose of this study alone. These issues, in addition to administrative delays and IT 
issues with the IRAS website, contributed to the lengthy process of obtaining ethical 
approval. 
This was further compounded by the Research Ethics Committee’s request to change the 
consent forms and the subsequent amendment submitted to extend recruitment and allow 
the following cohort of StRs to recruit patients for the study. 
10.1.2 CVM not present on lateral cephalogram 
In total there were 6 patients who had to be excluded from the final analysis, despite having 
several heights recorded, due to the vertebrae (C2, C3 and C4) not being present on the 
radiograph. This meant that it was not possible to use the radiographs and apply the CVM 
index. This highlights the importance of liaising with radiology departments to ensure that 
staff are aware of the correct patient positioning required when taking a lateral cephalogram 
to ensure that the second, third and fourth vertebrae are included on the lateral 
cephalogram. This issue was highlighted in the audit that was carried out and reported in 
Chapter 4.  
10.1.3 Patients not meeting inclusion criteria 
Patients who were not included in the data analysis due to not meeting the inclusion criteria 
totalled 4; all of these were due to the patient being too old, the ages of these 4 patients 
ranged from 19 to 30 years old. Despite the StRs involved being briefed on the inclusion 
criteria, it was inevitable that a few patients were recruited by mistake as a result of over 
enthusiastic recruitment. With the benefit of hindsight, it may have been worth including a 
checklist of the inclusion and exclusion criteria, in each surgery to serve as a reminder to the 
recruiting registrars; this may have reduced the number of patients recruited in error. 
10.1.4 First height not recorded within 6 months of lateral cephalogram 
The largest cause of patients having to be excluded from the analysis was due to lack of 
recorded information. The StRs involved were asked to record the height of the patient at the 
time their initial records were taken, and then after ethical approval had been obtained, at 
every appointment the patient attended. There were two main issues that were major 
limitations in the study. The first was that StRs did not always record the height of the patient 
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when they had their first cephalogram taken. This was not a problem if they recorded the 
height a few weeks later or even a few months later. However, there was a large number 
(n=41) where the height was not recorded for more than 6 months after the initial 
cephalogram. This meant that it was not possible to say for certain that the patient was at 
the CVM stage recorded on the radiograph when the first height was recorded. To ensure 
that this did not bias the results, any patients who had not had their first height recorded 
within 6 months of having their cephalogram taken were excluded. This unfortunately 
resulted in 41 patients being excluded from the final analysis and meant that the ideal 
sample size of 17 in the group, was not obtained for patients who were at CVM stages 1 and 
2.  
10.1.5 Patients with only one height recorded 
Another large limitation of this study related to data collection, was that many patients only 
had one height recorded. This meant that it was not possible to calculate an annualised 
growth velocity for these patients and thus they had to be excluded (n=26). 
Thus, in total, 77 patients had to be excluded from the final analysis, due to height 
measurements not being taken at the appropriate time(s). This was a substantial loss and 
their inclusion would have significantly increased the power of the study. It is however, a 
frequently encountered limitation of this type of research. Data collection depends on people 
without a vested interest in the study, collecting the data, and despite frequent reminders, 
the reality of busy clinics and being in a learning environment meant that it was inevitable 
that sometimes height recording was forgotten. If doing a similar study in the future, it may 
be of value to include a checklist to serve as a reminder to the recruiters of the steps 
required in the surgery in an attempt to reduce the extent of incomplete data collection. 
10.1.6 Sample size to assess mandibular growth 
Another limitation to this study was that only 36 of the patients who were in the final analysis, 
had two lateral cephalograms taken by the end of the data collection period. This meant that 
when measuring mandibular growth, the sample size was only 36. When this is broken down 
further into the different CVM stages, there were only 5 patients in the CVM stage 1 and 2 
group, and only 12 patients in CVM stage 5 and 6. Due to the small numbers involved, it was 
not possible to show any significant differences, even though some patterns could be seen 
in the differences in mandibular growth at each CVM stage. The data could therefore, only 
be described using the means, and these should be interpreted with caution due to the small 
numbers involved. 
23/10/2015 FINAL 
88 | P a g e  
 
10.1.7 Measuring mandibular growth 
There was much discussion on how best to measure mandibular growth. Various methods 
which have been described in the literature, were considered as discussed in section 2.6. 
However, regardless of how accurate or reliable the landmarks were that were measured 
(Co-Gn-Go), it is debatable as to how much this triangle actually represents real mandibular 
growth. Although cephalometric radiographs have been used extensively in orthodontic 
research to assess mandibular growth, it must be remembered that a cephalogram is a 
magnified two-dimensional image of a three-dimensional object. There are many errors 
associated with landmark identification, constructing linear measurements, and the 
measurement of linear and angular structures.134 Baumrind and Frantz134  suggested that the 
observed difference as a result of therapy should be at least twice the standard deviation of 
the estimating error, in order to be sure that the observed difference was a biological one 
rather than a measurement error. This suggestion appears reasonable when it is 
remembered that for each linear measurement, two estimations are being made thus there 
are two opportunities for errors to arise. Taking this into account, together with the 
knowledge that condylion is particularly prone to landmark identification error, the limitations 
of cephalometrics must be considered very critically when assessing cephlometric data. It 
has been suggested that three-dimensional radiographic imaging with cone-beam computed 
tomography (CBCT), that allows quantitative and qualitative analysis of bone is the only 
thing that can precisely measure the amount and direction of mandibular growth that has 
occurred.83 Clearly this was not something that could be considered in this study due to 
ethical contraindications of exposing patients to excess radiation.  
When considering the results from analysis of mandibular growth, it is important to interpret 
non-significant results with care. Lack of evidence of a difference in effect does not 
necessarily mean that there was no difference in effect.135 It is important to recognize the 
patterns shown whilst recognising that these means are based on very small numbers. 
Further efforts will be made to gather these data as the patients within the study finish their 
orthodontic treatment. 
10.1.8 Sample  
The sample was taken from the patients being taken on for treatment from the orthodontic 
treatment waiting list. This included only patients who had been assessed and deemed 
appropriate for treatment under the NHS and within a hospital department.  This may reduce 
the generalisability of the results, but as all patients were enrolled regardless of sex, skeletal 
classification or dental anomalies, this should have reduced bias. All ethnicities were 
included in the sample and this is a key difference between this sample and the sample from 
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the University of Michigan Growth Study. This may be a reason as to why the growth rates at 
CVM stages 1,2 and 5,6 were lower than the growth rates observed in the Franchi study, if 
there is a substantial variation in growth velocities in different ethnic groups. However, 
although data regarding participants’ ethnicity was not collected, anecdotally the majority of 
the sample was Caucasian, so it is unlikely that the ethnic diversity of the sample was large 
enough to affect growth rates significantly. 
 
10.2 Reliability Testing 
One of the principal characteristics of an outcome measure is its reliability. Reliability refers 
to the reproducibility of the measurement when repeated at random in the same subject or 
specimen. The coefficient of reliability is an estimate of the proportion of all variation that is 
not due to measurement error and is readily estimated from replicate measurements. The 
reliability of a measurement determines its sensitivity and specificity and the power of a 
statistical test employing the measurement. All decline as the reliability of the measure 
declines. The reliability of a measurement is an important consideration in the choice of the 
primary outcome measure for a clinical trial. Reliability of measures should be assessed and 
assured by a quality control program based on randomly selected duplicate assessments.  
With this in mind, inter-observer and intra-observer reliability was assessed for each of the 
three outcome measures i.e. CVM stage, statural height and cephalometric linear 
measurements. 
10.2.1: Reliability of CVM Index 
To assess the primary researcher’s reliability in applying the CVM index, a selection of 72 
images from patients at LUDH, in addition to ideal images provided by Professor J. 
McNamara, the co-author of the index, were assessed. This was done on two occasions 4 
weeks apart to determine intra-observer reliability. In addition, SH’s results were compared 
to JH’s results to assess inter-observer agreement and to calibrate SH in the use of the 
index. 
Agreement was assessed using Cohen’s weighted kappa. Cohen's kappa coefficient is a 
statistical measure of inter-rater agreement for categorical data. It is generally thought to be 
a more robust measure than simple percentage agreement calculation since kappa takes 
into account the agreement occurring by chance. The kappa value was rated according to 
the scale described by Landis and Koch,136 as demonstrated in Table 10.1. Other scales 
have been described such as that by Fleiss’s arbitrary guidelines137 (shown in Table 10.2). In 
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order to make the agreement data comparable to previous research27, the scale described 
by Landis and Koch136 was used. 
Kappa Value Agreement 
<0 No agreement 
0-0.20 Slight 
0.21-0.40 Fair 
0.41-0.60 Moderate 
0.61-0.80 Substantial 
0.81-1 Almost Perfect 
Table 10.1: Rating scale of kappa value described by Landis and Koch.136 
Fleiss’s Arbitrary Guidelines Agreement 
<0.40 Poor 
0.40-0.75 Fair to Good 
>0.75 Excellent 
Table 10.2: Rating scale of Fleiss’s arbitrary guidelines.137 
There was discussion over how to set the weightings when measuring inter- and intra-
observer agreement. Previous research has often given equal weightings to all categories so 
that if an observer is two categories away this is penalised twice as much as if they are one 
category away. On exploring the clinical implications of the weightings with regards to the 
CVM index, it was felt that an exponential weighting was more appropriate, so that if the 
observer is only one category off, the penalty is much less than if they are two categories 
away. This is because, despite the data being categorical, growth and indeed the change in 
shape of the vertebrae are continuous. In some cases the vertebrae are clearly defined as 
being a certain stage, however, there are instances where others are more difficult to 
assess, and are on the borderline of two stages. In this case, if a patient was a late stage 4 
and was staged as an early Stage 5, then it was felt that this should be penalised less than if 
the patient was, for example a Stage 4 and staged as a Stage 6. Thus, an exponential 
weighting scale was used, when calculating the kappa values, as shown in Table 10.3. 
The impact that the different weightings would have on the kappa value was explored and 
Table 10.3 shows an example of this for the inter-observer agreement between SH and JH 
using the 72 image sample of lateral cephalograms from LUDH. 
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Cohen’s 
Weighted Kappa 
Weighted by: 
1-abs(i-j)/(1-k) 
Weighted by: 
1-[(i-j)/(1-k)]² 
 
Ratings 
weighted by 
1 0.8 0.6 0.4 0.2 0 1 0.96 0.84 0.64 0.36 0 
Observed 
Agreement 
92.5% 97.4% 
Kappa 0.76 0.84 
 
Interpretation Substantial Agreement 
 
Almost Perfect Agreement 
Table 10.3: Demonstration of different kappa value and agreement with different 
weightings assigned to categories 
The Kappa statistic using equal weightings was 0.76 (92.5% observed agreement), which 
falls under the ‘substantial agreement’ category. The kappa statistic when the exponential 
weightings were used increased to 0.84 (97.4% observed agreement), which raises the level 
of agreement to ‘almost perfect’. This demonstrates the importance of using the most 
appropriate weightings. This will of course depend on the measure being assessed. In this 
situation for the CVM index, it was felt that the exponential weightings were more 
appropriate when taking into account the clinical implications. 
The intra-observer agreement had a kappa statistic of 1 (100% observed agreement); this 
falls under the ‘almost perfect’ category. The inter-observer agreement between researchers 
SH and JH was ‘almost perfect’, with an observed agreement of 97.4% Κw 0.84 SE (0.11) 
agreement. When comparing this to previous research, the most comparable study was the 
work done by Rainey,27  as the setting and training was the same as that which SH followed. 
In addition, whole lateral cephalograms were used rather than cropped images, and the 
vertebrae were not traced, in order that the setting was as relevant to the clinical setting as 
possible. The intra and inter –observer reliability of the researchers BJ and JH was ‘almost 
perfect’ with kappa values ranging from 0.80-1, which is comparable to the agreement of the 
researchers in this study. When looking at the overall agreement of the other clinicians in 
Rainey’s study, the agreement was ‘substantial’ with the mean intra-observer agreement 
being 0.70 and mean inter-observer agreement 0.67.27 Thus, the agreement in the current 
study was higher than the average clinician who had not previously used the index, but was 
similar to the researchers involved. This would agree with Rainey’s results that suggested 
that the amount of experience an observer had in using CVM, had a substantial impact on 
inter-observer reliability. This was demonstrated by the fact that the inter-observer reliability 
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for both the researchers in this study and in Rainey’s study, was in the ‘perfect agreement’ 
category. However, the inter-observer reliability for the other researchers was only 
‘substantial’.27  
10.2.2: Reliability of Statural Height Measurement 
The standing height of the patients in the study was carried out as recommended in the 
Tanner Whitehouse growth charts.63 The patients were positioned with their feet together, 
flat on the ground, with their heels touching the wall. Their legs were straight, with their 
buttocks against the wall and their arms loosely by their side. The patient’s head was 
positioned with the lower margins of the orbit in the same horizontal plane as the external 
auditory meati, i.e. with the Frankfort plane parallel to the floor. 
The reliability of all of the StRs was classified as excellent, with the intra-class correlation 
coefficients for intra-observer agreement ranging from 0.993 to 0.997. The inter-observer 
agreement was 0.986; this was also classified as ’excellent’ agreement. All of the Bland and 
Altman plots showed that the spread of the data was on the whole random, suggesting that 
there were no systematic errors of over or under measuring. Whilst there were outliers, there 
was usually no more than 1 per StR, which is probably inevitable in research of this type. In 
addition, the outliers were all within acceptable range from the limits of agreement. 
The Bland and Altman limits of agreement was used, in addition to correlation coefficients, 
as this is increasingly being used to assess at agreement of linear measurements in the 
orthodontic literature and this makes these data more comparable.  
The plot of difference against mean also allows any possible relationship between the 
measurement error and the true value to be investigated. The true value is not known, and 
the mean of the two measurements is the best estimate that could be obtained.130  
10.3: Assessing Mandibular Growth 
The agreement when measuring condylion-gonion 4 weeks apart was 0.93 (intra-class 
correlation coefficient); this is classed as excellent agreement. The ICC was the same for 
gonion-gnathion at 0.93, also classed as excellent agreement. Agreement for gnathion-
condylion was 0.85, this is classed as excellent agreement although it was lower than the 
agreement achieved with gonion-gnathion and gonion-condylion. A possible reason for this 
difference is that the primary researcher SH had as part of her normal practice regularly 
identified and used gonion as a cephalometric landmark. However, condylion and gnathion 
were two landmarks not commonly used previously; so it is interesting to note that the two 
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linear measurements containing gonion had a higher correlation coefficient than the 
measurement containing the two less familiar landmarks. 
10.4 Findings: How They Relate to Previous Research 
10.4.1: CVM Stage and Standing Height Velocity  
The mean annualised growth velocity (MAGV) increased by approximately 5cm/yr from CVM 
Stage 2 to CVM Stage 3. It then reduced by 4cm/yr from CVM Stage 3 to CVM Stage 4. The 
MAGV further reduces by 3.5cm/yr between CVM Stages 4 and 5. All of the differences in 
the MAGV between the stages were found to statistically significant (p=0.001-0.009) except 
between CVM stage 2 and 4, where there was no significant difference (p=0.95). It is 
perhaps surprising that the MAGV at CVM stage 1 and 2 wasn’t lower as it was expected to 
have a similar velocity to CVM stage 5 and 6. However, when the numbers were broken 
down, there was only one patient at CVM stage 1 in that group; thus the MAGV primarily 
reflects the growth velocity of CVM stage 2 patients. 
When comparing the results of this study, to the research that has been done previously in 
this area, the pattern of statural height growth velocity was similar to what Franchi et al20 
found in their research as shown in Table 10.4. They also reported a statistically significant 
increase in MAGV from CVM stage 2 to 3 and a significant reduction from CVM stage 3 to 4 
and again from CVM stage 4 to 5. However, some fundamental differences in the studies 
methodologies of the studies mean it is equivocal whether a direct comparison can be made. 
Firstly, Franchi et al.20 only had 24 patients in their study, so it is questionable as to whether 
their sample size was sufficiently powered to draw any solid conclusions. There was no 
power calculation mentioned in the article and the reason for choosing the sample size was 
not discussed. In addition, their data were more longitudinal in nature whereas the results of 
this study were more cross-sectional in nature looking at patients over a CVM stage over a 
1-year period. 
Although the trend of the MAGV is the same in this study as that of Franchi et al20, there is a 
key difference in that the peak growth velocities are higher in the current study. This may 
reflect modern day diets. It is widely recognised that dietary habits have changed vastly over 
the last century due to a combination of factors, including innovation of technologies in 
kitchens, improved modes of transport systems, trade, migration and increased incomes. 
These factors have led to higher levels of fat and protein consumption in children today.138 
Variables that can be used to assess the effects of modernisation on health are summarised 
by Baker and Hanna (1986) and include increased body weight, physical growth and 
development and stature.138 
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The sample used by Franchi et al20 was selected from the University of Michigan Elementary 
and secondary school growth study (UMGS). These patients were enrolled at the school 
from the mid 1930’s to the late 1960’s. Thus it is unsurprising that the current study shows a 
small increase in the MAGV in statural height compared to the figures quoted by Franchi et 
al.20 However, it is surprising that these differences weren’t larger given that the UMGS 
sample was selected 50-80 years ago. Even so, the data from the current study may reflect 
the changes explained by modernisation and change of dietary habits but will also have 
been influenced by the fact that the population treated in Liverpool is relatively deprived with 
50% of patients falling within the lowest quintile of the Index of Multiple Deprivation (IMD) 
rating.139 This suggests that a high proportion of patients included in the current study may 
have been from some of the most deprived areas in the UK. These issues highlight the 
importance of conducting research on a contemporary population, as this will give us a more 
accurate idea of how much growth can be expected in patients at each CVM stage but also 
suggest that other factors that contribute to growth need to be considered.  
 
Table 10.4: Comparison of the MAGV from this study to Franchi et al. (2000) results  
Table 10.4 and Figure 10.3 demonstrate the similarity in trend between the results of the 
current study and the work of Franchi et al.20 Looking at the line graph in Figure 10.3, the 
peak growth velocity in the LUDH is slightly higher than the figure reported in the Franchi 
study. However, It is surprising that the growth velocity at CVM Stages 1, 2, 5 and 6 is higher 
in the Franchi et al. study than in the LUDH sample. It is difficult to say for certain why this is 
but again may be a reflection of the small sample sizes in each CVM group or differences in 
the populations measured with respect to time lag and socio-economic group. In order to 
provide more robust data, a much larger sample size, especially of patients in CVM stages 
1&2 and 5&6, would be required and this could be the topic of future research. 
CVM 
Stage 
Mean annualized 
growth rate (cmy-1) 
(LUDH n=108) 
2014 
SD 
Mean annualized 
growth rate (cmy-1) 
(Franchi et al.20 n=24) 
1930-1960 
SD 
Mean 
Difference 
(cmy-1)  
[95%CI] 
1 & 2 4.51 2.71 5.69 1.34 
-1.18 
[-2.69, 0.33] 
3 9.39 4.44 8.70 1.7 0.69 
[-1.52, 2.90] 
4 5.00 2.33 4.96 2.1 0.04 
[-1.87, 1.95] 
5 & 6 1.56 2.34 3.35 1.78 
-1.79 
[-3.48, -0.10] 
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Figure 10.3: Line graph showing MAGVs at different CVM stages for this study and its 
comparison to the Franchi et al. (2000) study. 
Mitani and Sato (1992) investigated growth of the mandible, in relation to cervical vertebral 
maturation and standing height.73 They showed a consistent strong correlation between 
body height and cervical vertebrae, however, they presented their results in terms of 
chronological age rather than stage of cervical maturation stage thus a direct comparison is 
not possible. 
As well as the strong correlation between CVM stage and standing height growth velocity, 
many authors have reported a strong correlation between standing height growth velocity 
and mandibular growth73. Van der Beek et al72 showed that the growth velocity of standing 
height was a good indicator for mandibular growth velocity. However, different measures 
were used to assess mandibular growth so comparison with the current study is difficult. The 
parameters they used for mandibular growh were sella-gonion (S-Go) and nasion-gnathion 
(N-Gn). They found a stronger relationsip with standing height growth velocity and S-Go than 
standing height and Na-Gn. 
 
This confirms the work by Hunter,11 Grave,140 Moore et al,71 and Thompson et al,141 Hunter,11 
concluded that in 86% of their sample, maximum increments in mandibular growth were 
reached either coincident to (57%) or after (29%) the peak in standing height growth velocity.  
Lewis et al.142 found that periods of accelerated growth in ramus height coincided with those 
in standing height. In addition, Moore et al.71 also found the largest correlations for standing 
height  was with sella-gonion. 
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Though these results are encourging and their findings are corroborated by the results of this 
study, there is a significant gap in the research in this area. Prior to this study, research had 
usually been based on historical populations and conducted retrospectively. In addition, 
there is a large amount of variation in the parameters used to measure mandibular growth so 
any statistical comparison is difficult. Further research needs to be carried in this area and a 
standardised method of assessing mandibular growth, without the need for additional 
radiation exposure that the use of CBCT would involve, needs to be defined. 
10.4.2: CVM Stage and Age 
The results of this study showed that girls were reaching their peak growth spurt at an earlier 
age than boys. The average age of girls at CVM stage 3 was 12.4 years (age range 10.6-
13.6 years, 95%CI 11.46;13.36) whereas the average age of boys at CVM stage 3 was 13.6 
years (age range 11.8-14.5 years, 95%CI 13.06;14.09). This supports previous research, 
which reports that girls tend to have their peak in growth spurt prior to boys.13, 50-52 Franchi et 
al.20 reported that at CVM stage 3, chronological age for females ranged from 8 years 6 
months to 11 years 5 months, whereas for the boys it ranged from 10 years to 14 years. 
Thus, the authors argue that the differences in these age ranges demonstrate why 
chronological age cannot be used as a parameter for the appraisal of individual skeletal 
maturation and for the definition of treatment timing. 
 
Recently, Beit et al.47 suggested that CVM staging was no better at predicting the peak in 
growth than chronological age. However, their sample was taken from a retrospective growth 
study carried out in 1981. Furthermore, these data suggest that there was no significant 
difference in the ages between CVM stages 1-2, 3 and 4. This contrasts with mean 
annualised growth velocity, where a very significant difference was found between the 
different CVM stages. The findings of the current prospective study would therefore suggest 
that CVM is much more valid as a predictor of growth than chronological age. 
 
When comparing the mean age at each CVM stage in the current study with the mean age 
at each CVM Stage in the Franchi et al.20 study, it can be seen (in Table 10.5) that generally, 
the patients in the current study were older at each stage than in Franchi et al. This is 
perhaps surprising when the literature tends to suggest that children are tending to go 
through puberty at an earlier age currently than they did historically. 
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Table 10.5: A comparison of the mean age at each CVM stage from this study and 
from the Franchi et al.20 study. 
10.4.3: How Valid Are These Results?  
The reliability results all show excellent inter-and intra observer agreement. The differences 
in MAGV between the CVM stages were statistically significant, with the p value ranging 
from 0.001 to 0.009. However, the sample size in the group containing CVM stages 1 and 2 
was underpowered by 3 patients fewer relative to the original sample size calculation. 
However, despite this, the results were significant, so the number of participants was 
sufficient to detect a statistically significant difference. It is unlikely that these results and 
significance would have changed if 3 more patients had been in this group. An inadequate 
sample size is an issue when there is no significant difference, because it is unknown 
whether the result of no difference is due to the sample being underpowered or whether 
there is truly no difference. However, as the results of this study were highly statistically 
significant, on discussion with the statistician (G.Burnside) it was felt that the study was 
adequately powered. 
10.4.4: CVM Stage and Mandibular Growth Velocity  
The results assessing the mean rate of mandibular growth at the different CVM stages, as 
identified in Chapter 9, were inconclusive due to the small sample size. They will, therefore, 
be discussed with regards to the general trends displayed with the knowledge that firm 
conclusions cannot be drawn based on these data, and that a much larger sample size 
would be required to provide sufficient power to detect a significant difference. 
The peak in mandibular growth occurred at two stages, CVM stages 3 and 4 where the 
mean annualised mandibular growth rate was 0.448cm2y-1 and 0.446cm2y-1 respectively. The 
rate was lower at CVM stages 1 and 2 at 0.192cm2y-1 and again was lower at CVM stages 
5/6 at 0.257cm2y-1. 
CVM 
Stage 
Mean Age (Years) 
LUDH 
 
Mean Age (Years) 
(Franchi et al20 n=24) 
 
Difference 
(Years) 
 Mean Age 95%CI Mean Age 95%CI  
1 & 2 12.71 12.01 13.41 9.10 Data not available 2.91 
3 13.15 12.65 13.65 10.67 Data not available 2.48 
4 13.55 13.00 14.11 11.68 Data not available 1.87 
5 & 6 15.23 14.76 15.70 13.25 Data not available 1.98 
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When an ANOVA test was carried out, to test the null hypothesis of no difference between 
the groups, no significant difference could be detected between any of the groups for the 
area of the triangle Co-Go-Gn or for any of the 3 linear measurements making up the 
triangle. This again, is likely to be due to the small sample size. 
When the results of this research were compared to other research, looking at mandibular 
growth velocity at different CVM stages, the trend is comparable to other authors’ work. The 
results of research looking at the velocity of mandibular growth in relation to CVM stage, are 
divided; some studies have found that peak mandibular growth velocity coincides with CVM 
stage 3 or peak standing height growth velocity.13, 33, 34, 71 However, there is also a body of 
evidence to suggest that the peak mandibular growth velocity occurs just after the peak in 
standing height growth velocity or after CVM stage 3 and this ‘time-lag’ effect has been 
documented many times in the literature.70 
O’Reilly et al18 showed that the peak in mandibular growth occurred between CVM stage 3 
and 4 as shown in Figure 10.4. The mean mandibular growth velocities on the graph at 
Stage 3 and Stage 4 are similar and are placed on the slope of the curve either side of the 
peak. This would explain the similar rates of mandibular growth at CVM stage 3 and 4 that 
were obtained in the LUDH study. However, in the O’Reilly et al.18 study, mandibular length 
was measured using articulare as a landmark. As discussed, it is controversial as to the 
accuracy of this landmark to assess mandibular growth. An increase in mandibular length 
can be presumed when the condyles are simply positioned more anteriorly within the glenoid 
fossa. 
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Figure 10.4: Mandibular growth at different CVM stages. Modified from O’Reilly et al18. 
Hunter13 found that there was a relatively high correlation between the gain in length of the 
mandible and statural height in both males and females (r=0.76). The increase in the length 
of the mandible was also closely related to the growth in statural height during the 
adolescent growth spurt. They concluded that maximum facial growth was coincident with 
maximum growth in height in the majority of subjects in the study; furthermore, they 
concluded that the anteroposterior length of the mandible, of all facial dimensions, exhibited 
the most consistent relationship with growth in height throughout adolescence.13 However, 
these results do need to be interpreted with caution, as the sample was a sample of 
convenience that was not randomly selected and was obtained from the child research 
council, Denver Colorado. This was undertaken from the early 1930s and growth patterns as 
well as population demographics may have changed over the last eighty years. 
More recently, Gu et al.143 also reported that the peak in mandibular length was observed 
during the interval between CVM stage 3 and CVM stage 4 even though mandibular 
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remodeling and growth continued over a relatively long time period after the peak in 
mandibular growth had occurred. 
Furthermore, Bergersen33 reported that there was a significant correlation between the 
growth of all facial dimensions including mandibular growth and standing height. It was 
shown in his research that there was no significant difference between peak mandibular 
length growth velocity and peak standing height growth velocity.  
Several other authors have also reported that the peak in mandibular growth velocity 
coincides with a peak in standing height growth velocity.13, 77 
Mitani and Sato73 looked at the size of the mandible in relation to CVM stage, and found that 
they were strongly correlated up to the age of 11, but then this correlation weakened. 
Despite them reporting a significant correlation between standing height growth velocity and 
CVM, they found that the mandible showed substantial variation in its timing of peak growth. 
Despite this, it was reported that within a limit of a 1-year lag, the peak growth of the 
mandible coincided with peak growth of standing height in 73% of the sample and with CVM 
in 82% of the sample. Without the time lag, the timing of peak mandibular growth was not 
highly correlated to any parameter. However, to assess mandibular growth, they only 
measured condylion-gnathion. This may risk missing any mandibular growth that has 
occurred at gonion and within the mandibular ramus.  It is therefore difficult to make a direct 
comparison of these results and those obtained in the current study, regarding mandibular 
growth due to the different parameter measured; this highlights the importance of more 
research in this field using standardized methodologies so that results are comparable. 
Other research reported that the peak in mandibular growth velocity occurred slightly later 
than the peak in standing height growth velocity includes Fishman et al.,38 who reported that 
the mandibular growth velocity peaked later than statural height peak velocity. In their 
research, it was found that statural height demonstrated a greater percentage of completed 
growth than mandibular and facial growth in mid-late adolescence.  This pattern of a lag 
between statural height peak growth and mandibular peak growth has also been reported by 
other authors.35, 78 
Bacceti et al.16 reported that the peak in mandibular growth velocity occurred at CVM Stage 
3, which differs slightly from the findings of the current study where the peak in mandibular 
growth seems to be concentrated at CVM Stages 3 and 4. However, it is equivocal as to 
whether a comparison can be made as in the Bacceti et al. study, they used records from 
the University of Michigan study, which, as discussed previously, is an historic sample, and 
the study was carried out retrospectively. Although the value of serial lateral cephalograms 
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and height measurements from the historic growth studies must not be underestimated, 
prospective longitudinal studies, using a contemporary population, are preferable on which 
to draw valid conclusions. 
In summary, peak growth velocity in standing height has been shown to be one of the most 
accurate methods of determining the overall skeletal growth velocity. Despite the variations 
in the methodologies of the studies carried out previously in this area, a consistent positive 
relationship between peak in height and peak in mandibular growth, with or without a time 
lag, has been demonstrated. This suggests that mandibular growth peaks around CVM 
stages 3 to 4, which is consistent with the results of the current study, within the limitations 
regarding sample size. 
10.5 Applicability of Results 
The population from which the participants were recruited was those patients of two 
consecutive cohorts of registrars at LUDH, who ranged in age from 8 to 18 years old. Males 
and females were included from all ethnic backgrounds, undergoing all modalities of 
orthodontic treatment. This was in an attempt to increase the generalisability of the results. 
Patients diagnosed with any congenital clefts of the lip and/or palate, or known or suspected 
craniofacial syndromes or growth related conditions were excluded. This was so that any 
syndromic effects on growth did not confound the results.  
Using a population from a dental hospital means that the results of this study may be 
applicable to the larger population that undergoes orthodontic treatment. The setting in an 
NHS Dental Hospital was common to many cities in the UK. Despite this, the fact that it was 
only set in the dental hospital in Liverpool may limit the generalisability of the results to some 
extent due to variations in the populations that attend for treatment around the UK. Ideally, 
the study could be expanded to include both primary and secondary care settings and 
potentially a multi-centre study so that the results would be generalisable nationwide. 
The sample for the current study was a sample of convenience, as the aim was to recruit a 
large enough sample to detect a significant difference in the annualised growth velocity 
between the different participants at different CVM stages, with an 80% power at a p value of 
0.05. However, the sample was not selected randomly, thus the risk of selection bias must 
be considered. Registrars were asked to recruit all patients who met the inclusion criteria 
and who consented to being in the study. It could be argued that the registrars, because they 
knew their patients, would make a decision whether to ask them or not, and may consciously 
or sub-consciously have introduced some selection bias. In addition, the sample was not 
balanced across the CVM stages. 
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10.6 Implications for Clinical Practice 
 This method of assessment of CVM stage provides clinicians with information for 
assessing the timing of peak statural height growth and potentially peak mandibular 
growth. 
 Growth is a critical variable in orthodontic treatment. A treatment plan can vary from 
involving orthognathic surgery to camouflage with the extraction of teeth to functional 
appliance treatment on a non-extraction basis, depending on a patient’s growth potential. 
By assessing the cervical vertebrae on a lateral cephalometric radiograph, the 
orthodontist can now potentially evaluate the growth stage of the patient at that point in 
time. This will provide the orthodontist with a reasonable idea as to how much growth 
should be factored into anticipated treatment. 
 With regards to treatment timing: patients being considered for functional appliance 
therapy can be assessed with regards to their current growth velocity and future growth 
potential. 
 Patients being considered for surgical treatment or dental implants will have a clearer 
idea of the timing of their treatment based on an assessment of the amount of growth 
they have remaining 
 As a lateral cephalometric radiograph is already routinely required for a full orthodontic 
assessment, this information is readily available to the orthodontist and will obviate the 
need for additional hand–wrist radiograph thus reducing radiation dose to the patient. 
10.7 Implications for Future Research  
 Further research into the velocity of mandibular growth at each CVM stage would be a 
logical step after this research. If clinicians knew how much mandibular growth could be 
expected at each stage, this may have a huge impact on orthodontic treatment planning. 
A larger sample size and longer study duration would be required. 
 
 It would be of interest to conduct this research as a multi-centre, prospective study to 
assess whether the results are similar across the UK. The implications of validating the 
CVM method on clinical practice would be invaluable. 
 
 It would also be valuable to examine the influence of ethnicity upon growth rates. As 
discussed, the ethnic mix of the sample in this study is likely to be more diverse than the 
sample used in Franchi et al’s study and thus it would be insightful to account for this 
factor to see if this explained for the differences in growth velocities at CVM stages 1,2,5 
and 6. 
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 In addition, the influence of the Index of Mulitple Deprivation may have an affect on a 
participant’s growth velocity. Liverpool is a diverse city, and many of the participants may 
come from deprived backgrounds and this may be a factor that affects growth velocity. A 
larger sample is likely to be required in order to assess the affect of the Index of Multiple 
Deprivation upon growth velocity. 
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Chapter 11: Conclusions 
 
 The findings of this study demonstrate the validity of the cervical vertebral maturation 
(CVM) method for the identification of the pubertal peak in statural height growth rate 
with statistically significant differences being found in the mean annualised height growth 
rate between all the CVM stages except between Stages 2 and 4. 
 The peak in statural height growth velocity occurred at CVM Stage 3 in both males and 
females. 
 The females at CVM Stage 3 were significantly older than the males. 
 The peak in statural height rate, at CVM Stage 3, occurred slightly ahead of the peak in 
mandibular growth rate, as assessed by the triangle condylion-gonion-gnathion, at Stage 
3 and 4. 
 No significant differences could be demonstrated between the CVM stages with regards 
to mandibular growth rate velocity due to the sample size. 
 The CVM method can be used to augment other diagnostic tools available to the 
orthodontist, as it is already available on the lateral cephalogram.   
 By assessing the CVM stage, the orthodontist can gain an idea of how much potential 
growth should be factored into the treatment plan. 
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Appendix 1: Participant Information Leaflet 
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Department of Orthodontics          
Liverpool University Dental Hospital and School of Dentistry 
Pembroke Place, Liverpool L3 5PS  
 
PARTICIPANT INFORMATION SHEET 
 
Is cervical vertebral maturation (CVM) a good predictor of growth? 
 
What is the purpose of the study? 
As Orthodontists we regularly treat patients, like you, who are growing and maturing as they 
grow up from a child, to a teenager and then to an adult.  Predicting how much patients will 
grow may affect the type of braces we offer them and the result they get from their 
treatment.  Cervical vertebral maturation (CVM) is a measure taken from the neck bones on 
the X-ray pictures we use routinely as part of your treatment. Your orthodontists will check 
these as a routine part of their assessment process.  Some research suggests that CVM 
may provide valuable information about growth, which may allow us to predict how much 
growth we can be expect. This would then allow us to target treatment better and, 
potentially, reduce the length of orthodontic treatment. 
Has the study been approved? 
Yes. Liverpool Local Research Ethics Committee has given the approval for this study. 
Who is paying for the study? 
The School of Dental Sciences of the University of Liverpool is paying for the study.  The 
Royal Liverpool and Broadgreen University Hospital Trust and the University of Liverpool are 
co-sponsoring the study. 
Who will be conducting the study? 
The study is being led by Dr Jayne Harrison (Consultant in Orthodontics) and carried out 
Sara Hosni, Ayeh Mahdmina, Andy Garry and Muneera Al-Mazyad (Specialist Registrars in 
Orthodontics). 
Why have you asked me to take part?  
We asked you to take part in this study because you are having orthodontic treatment and 
are still growing. 
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What will I have to do? 
You will have your height measured at each of your routine orthodontic appointments.  Your 
treatment will be different in no other way. 
How long will the study last? 
The study will last for the full length of your treatment. 
What happens if I don’t want to take part? 
If you don’t want to take part in the study, your treatment will continue as normal.  You do not 
have to take part in the study and shouldn’t feel you have to take part. If you don’t want to 
take part in the study, you don’t have to give us a reason.  If you do take part in the study, 
but then decide that you don’t want to carry on, you can withdraw at any time without giving 
a reason. 
What if I have a question or there is a problem on the study? 
If you have a concern about any aspect of this study, you or your parent(s) should ask to 
speak a member of the research team on 0151 706 5252. They will do their best to answer 
your questions. If you or your parents are still unhappy and wish to complain formally, your 
parents can do this through the Patient Advice Liaison service or by emailing; 
complaints@rlbuht.nhs.uk. Details can be obtained from 
http://www.rlbuht.nhs.uk/for_patients/Complaints_FAQs.asp 
How will you collect and look after data (information) about me? 
No one will be able to identify any of the data we collect about you. As soon as we have 
collected the necessary data, we will remove all information that identifies you and replace it 
by a code number. Only members of the research team will process and analyses your data.  
The person responsible for security and access to your data is Dr Jayne Harrison, the Co-
Chief investigator of the Study. The data will be stored safely for ten years.  
What do I do if I want to take part? 
If you would like to take part in our study, please sign all the appropriate parts of the consent 
form that we will give you. 
 
THANK YOU FOR TAKING THE TIME TO READ THIS LEAFLET 
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Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
 
CONSENT FORM 
 
Title of Project:  Is cervical vertebral maturation (CVM) a good predictor 
of growth? 
 
Name of Researcher:  Sara Hosni 
Please initial box  
 
 
1.  I confirm that I have read and understand the information 
sheet dated January 2013 (version 2) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2.  I understand that my participation is voluntary and that I am 
free to withdraw at any time without giving any reason, without 
my medical care or legal rights being affected. 
 
 
3.  I understand that the data collected during the study will be 
analysed by the study investigators. I give permission for these 
individuals to have access to my records. 
 
 
4.  I agree to take part in the above study. 
 
 
 
 
__________________________   ____________   ______________________ 
Name of participant    Date    Signature  
 
 
__________________________   ____________   ______________________ 
Name of Person     Date    Signature  
taking consent  
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Department of Orthodontics         
Liverpool University Dental Hospital and School of Dentistry 
Pembroke Place, Liverpool L3 5PS  
 
PARENT INFORMATION SHEET 
 
Is cervical vertebral maturation (CVM) a good predictor of growth? 
 
What is the purpose of the study? 
As Orthodontists we regularly treat patients, like your child, who are growing and maturing 
as they grow up from a child, to an adolescent and then to an adult.  Predicting how much 
patients will grow may affect the type of braces we offer them and the result they get from 
their treatment.  Cervical vertebral maturation (CVM) is a measure taken from the neck 
bones on the X-ray pictures we use routinely as part of your child’s treatment. Your child’s 
orthodontists will check these as a routine part of their assessment process.  Some research 
suggests that CVM may provide valuable information about growth, which may then allow us 
to predict how much growth we can expect. This would then allow us to target treatment 
better and potentially, reduce the length of orthodontic treatment. 
Has the study been approved? 
Yes. Liverpool Local Research Ethics Committee has given the approval for this study. 
Who is paying for the study? 
The School of Dental Sciences of the University of Liverpool is paying for the study.  The 
Royal Liverpool and Broadgreen University Hospital Trust and the University of Liverpool are 
co-sponsoring the study 
Who will be conducting the study? 
The study is being led by Dr Jayne Harrison (Consultant in Orthodontics) and carried out by 
Sara Hosni, Ayeh Mahdmina, Andy Garry and Muneera Al-Mazyad (Specialist Registrars in 
Orthodontics). 
Why have you been asked my child to take part?  
We asked your child to take part in this study because he/she is having orthodontic 
treatment and is still growing. 
 
What will I have to do? 
Your child will have his/her height measured at each of their routine orthodontic 
appointments.  Their treatment will not be different in any other way. 
How long will the study last? 
The study will last for the full length of your treatment. 
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What happens if I don’t want to take part? 
If you don’t want your child to take part in the study, his/her treatment will continue as 
normal.  Your child does not have to take part in the study and you shouldn’t feel you have to 
let them take part. If you don’t want your child to take part in the study, you don’t have to 
give us a reason.  If your child does take part in the study, but then you decide that you don’t 
want them to carry on, you can withdraw your child at any time without giving us a reason for 
doing so. 
What if I have a question or there is a problem on the trial? 
If you have a concern about any aspect of this study, you should ask to speak to a 
member of the research team on 0151 706 5252. They will do their best to answer 
your questions. If you are still unhappy and wish to complain formally, you can do 
this through the Patient Advice Liaison service or by emailing; 
complaints@rlbuht.nhs.uk. Details can be obtained from 
http://www.rlbuht.nhs.uk/for_patients/Complaints_FAQs.asp 
 
How will you collect and look after data (information) about my child? 
No one will be able to identify any of the data we collect about your child. As soon as we 
have collected the necessary data, we will remove all information that identifies your child 
and replace it by a code number. Only members of the research team will process and 
analyses your child’s data.  The person responsible for security and access to your child’s 
data is Dr Jayne Harrison, the Co-Chief investigator of the Study. The data will be stored 
safely for ten years.  
What do I do if I want to take part? 
If you would like you child to take part in our study, please sign all the appropriate parts of 
the consent form that we will give you. 
 
THANK YOU FOR TAKING THE TIME TO READ THIS LEAFLET. 
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Appendix 4: Parent/Guardian Consent Form 
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Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
 
CONSENT FORM FOR PARENT/LEGAL GUARDIAN 
 
Title of Project:  Is cervical vertebral maturation (CVM) a good predictor 
of growth? 
 
Name of Researcher:  Sara Hosni 
Please initial box  
 
1.  I confirm that I have read and understand the information 
sheet dated January 2013 (version 2) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
 
2.  I understand that my child’s participation is voluntary and that I 
am free to withdraw my child at any time without giving any 
reason, without my medical care or legal rights being affected. 
 
 
3.  I understand that the data collected during the study will be 
analysed by the study investigators. I give permission for these 
individuals to have access to my child’s records. 
 
 
4.  I agree for my child to take part in the above study. 
 
 
 
__________________________   ____________   ______________________ 
Parent/Legal guardian    Date    Signature  
 
 
__________________________   ____________   ______________________ 
Name of Person     Date    Signature  
taking consent  
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Appendix 5: Child Assent Form 
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Department of Orthodontics          
Liverpool University Dental Hospital and School of Dentistry 
Pembroke Place, Liverpool L3 5PS  
 
INFORMATION SHEET AND ASSENT FORM 
 
We want to tell you about a research study we are doing.  A research 
study is a special way to find out about something.  We are trying to find 
out more about growing up. You are being asked to join the study 
because you are growing. 
Why are we doing this study?  
We treat lots of patients, like you, who are growing up. Knowing how much patients will grow 
might change what type of brace we give and how well the brace works.  We can learn about 
growth by looking at the x-ray pictures we took of you. We can also learn more about it by 
measuring your height. 
Why have you asked me to take part?  
We asked you to take part in this study because you are wearing a brace and you’re still 
growing.  
What will I have to do? 
We will measure your height every time you come to see us.  This is the only extra thing we 
will do for the study. 
Do I have to take part? 
No, you don’t have to be in the study.  It’s up to you.  If you say yes now, but you change 
your mind later, that’s okay too.  All you have to do is tell us. 
Can anything good happen to me? 
It won’t change your brace treatment.  But we hope to 
learn something that will help other children one day. 
How long will the study last? 
The study will last until you finish your braces come off. 
Will anyone know I am in the study? 
We won’t tell anyone you were in this study. When we 
have finished the study, we will write a report about 
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what we found out.  We won’t use your name in the report. 
What if I have a question or there is a problem on the study? 
If you have a question about the study, or if you are worried about anything, you or your 
parent can ask me when you come to have your brace checked. 
What do I do if I want to take part? 
If you want to be in this study, please sign or print your name on the next page.  
 
Assent 
 
1.  I have read and understand the information about the 
study. I have asked any questions I wanted to and these 
have been answered. 
 
 
2.  I understand that I don’t have to be in the study and I can 
change my mind any time without giving a reason. 
 
 
3.  I understand that the research team will be looking at my 
height and x-ray pictures. I give permission for them to 
look at my records. 
 
 
4.  I agree to take part in the above study. 
 
 
 
 
__________________________   ____________   ______________________ 
Name of participant    Date    Signature  
 
 
__________________________   ____________   ______________________ 
Name of Person     Date    Signature  
taking assent  
 
 
 
THANK YOU FOR READING THIS LEAFLET  
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Appendix 6: Standing Height Table 
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Date Standing Height (cm) 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 Patient 
Sticker 
Weight at first appointment:  
